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                                                        Abstract 
 
(A) In recent years, considerable amount of effort has contributed towards enhancing our 
understanding of the new photoswitch, cyclic azobenzene, particularly from the theoretical point 
of view. However, the challenging part with this system was poor efficiency of its synthesis from 
2,2’- dinitrodibenzyl and lack of effective methods for further modification which would be 
useful to incorporate this system into biomolecules as a photoswitch. We report the synthesis of 
cyclic azobenzene and analogues from 2,2’-dinitrodibenzyl, which would allow for further 
incorporation of this cyclic azobenzene into biomolecules. Reaction of 2,2’-dinitrodibenzyl with 
zinc metal powder in the presence of triethylammonium formate buffer (pH-9.5) gave a cyclic 
azoxybenzene, 11,12-dihydrodibenzo[c,g][1,2]diazocine-5-oxide. The latter compound was 
converted into cyclic azobenzene analogues (bromo-, chloro-, cyano-, and carboxyl) through 
subsequent transformations. The carboxylic acid analogue was reacted with D-threoninol to give 
the corresponding amide, which readily undergoes photo-isomerization upon illumination with 
light. Upon illumination with light at 400 nm, approximately 70% of cis- isomer of amide was 
isomerized to trans- isomer. It was observed that cis- to trans- isomerization reached the 
maximum steady state of light transmission after approximately 40 min, whereas the trans- to 
cis- isomerization approximately acquired in 2 h to regain full recovery of light transmission. 
Cyclic azobenzene phosphoramidite was synthesized from DMT-protected D-threoninol linked 
cyclic azobenzene. 
 
 
 ii 
 
 
(B) In recent years, there has been considerable interest invested towards the synthesis of 
azobenzene analogues for incorporation into proteins. Among the many azobenzene analogues, 
the synthesis of bi-functional cyclic azobenzene analogues for the incorporation into proteins is 
relatively new. In this thesis, we report the synthesis of a cyclic azobenzene biscarboxylic acid 
from 4-(bromomethyl)benzonitrile.  
(C) Azobenzene has been widely used in the field of polymer science to study the surface 
morphology and surface properties of polymers. In this thesis, we report the incorporation of 
cyclic azobenzene into a commercial polymer 2-(hydroxyethyl)methacrylate. Samples collected 
after 24 h from the reaction solution showed approximately 9% of incorporation of cyclic 
azobenzene into polymer compared to samples collected after 10 h, which showed approximately 
6% incorporation. 
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CHAPTER 1- Nucleic acids and photoresponsive molecules 
1.1 Introduction to nucleic acids 
Nucleic acids, first discovered by Friedrich Miescher in 1869,
1, 2
 are high molecular weight 
biopolymers essential for all known forms of life. Nucleic acids are composed of mainly three 
components, a nucleobase (purine and pyrimidine), a sugar unit (pentose sugar), and a phosphate 
group (Figure 1). 
             
Figure 1. Structures of purine and pyrimidines and sugar-phosphate group in nucleic acids. 
Adenine and guanine form the purines whereas cytosine and thymine form the pyrimidines in 
DNA. The nucleobase and a sugar (2ʹ-deoxyribose or ribose sugar) moiety together form a 
nucleoside.  
2 
 
 
A nucleotide is formed if a phosphate group is attached to the 5ʹ-OH of the sugar. Nucleotides 
are connected through phosphodiester linkages between 5ʹ-OH and 3ʹ-OH on two adjacent 
nucleosides, which essentially form the backbone of the nucleic acids (Figure 2). Two basic 
kinds of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA and 
RNA are made up of deoxyribose and ribose sugar, respectively. In addition, thymine in DNA is 
replaced with uracil in RNA; uracil lacks a methyl group on its heterocyclic ring.  
 
Figure 2. Chemical structures of a) DNA and b) RNA.  
Nucleic acids are involved in encoding, transfer, and expression of genetic information via 
replication, transcription and translation. The DNA acts as repository of genetic information 
which is transcribed into RNA.
3
 The encoded genetic information from RNA is then used to 
guide protein synthesis through a process known as translation.
4
  
The order of the specific sequence in which the four DNA nucleobases are connected constitutes 
the genetic information, the blueprint for the construction of the essential building blocks of life, 
proteins.  
3 
 
 
In nature, most DNA molecules are double stranded, and RNAs are single-stranded. DNA 
duplexes consist of two anti-parallel strands brought together by base pairing as a result of 
hydrogen bonding. It follows that, in the canonical Watson-Crick base pairing, guanine forms 
three sets of hydrogen bonds with cytosine and adenine forms two sets of hydrogen bonds with 
thymine (Figure 3).  
                                
Figure 3. Base-pairing pattern in DNA. 
In DNA duplexes, the two strands run antiparallel to each other, i.e., one strand runs in 5ʹ-3ʹ 
direction whereas the other strand runs in 3ʹ-5ʹ direction (Figure 3). One of the strands in the 
DNA duplex acts as the template strand, while the other acts as the replicating strand. The 
replicating strand is self-duplicated using the template strand in the DNA duplex. DNA can exist 
in three different conformations, A-, B-, and Z-forms, of which B-DNA is the most common 
form. In this form, the phosphodiester backbone of DNA is twisted around its longitudinal axis 
to form a right-handed double helix with a hydrophilic backbone of alternating 2ʹ-deoxyribose 
groups and negatively charged phosphate groups situated on the outer part of the helix.  
 
4 
 
 
Two distinct grooves are formed and run along the side of the helix. The major groove is wide 
and deep, while the minor groove is narrow and deep.  
The DNA duplex is 22 to 26 Å wide and the rise per nucleotide residue is approximately 3.3 Å in 
B-DNA.
5
 In chromosomes, DNA is packed into coiled structures. These chromosomes are 
replicated in a process called DNA replication. In eukaryotic organisms (animals, plants, fungi, 
and protists), DNA is stored inside the cell nucleus. In contrast, prokaryotes store their DNA in 
the cytoplasm.
6
  
All the necessary information required for the development of an organism (prokaryotes and 
eukaryotes) throughout life is encoded in DNA, although, in some viruses, RNA stores genetic 
information. Therefore study of biological processes, such as hybridization, transcription, and 
translation will provide insight on biochemical roles of nucleic acids. In addition, studying the 
interactions of DNA with proteins will confer more insight into various biomolecular functions 
such as gene expression, replication and repair mechanisms. 
1.2 Photoregulation of functions of biomolecules 
Recently, much attention has been focused on understanding the etiology and pathophysiology of 
various diseases such as Alzheimer’s disease, as well as the involvement of molecules in over- 
and under- expression of proteins and genes.  
There has been a great amount of work over the past two decades in artificially controlling gene 
expression and protein functions. Functional regulation of various biomolecules, such as DNA, 
RNA, proteins, and enzymes, has been achieved by different methods such as small molecules, 
gene therapy, antisense oligonucleotides, and small interfering RNA (siRNA).  
5 
 
 
The above methods are effective but often lack selectivity as well as spatio-temporal control. 
One approach to achieve selectivity and spatio-temporal control is by regulating a particular 
cellular function by placing the system of interest under the control of internal or external 
stimuli. For nucleic acids, external stimuli such as light could play very crucial roles in 
regulating the functions of nucleic acids. This approach can provide insight into the mechanisms 
vital for DNA recognition and DNA-mediated bioprocess.  
Light works best as an external stimulus and has several advantages over other external stimuli 
such as heat: 1) no contamination from light to the reaction system, 2) control of excitation 
wavelength can be achieved through the design of photoresponsive molecules, and 3) ease of 
controlling irradiation time and local excitation.
7
 Indeed light has been used clinically, for 
example, in treating patients or blood samples from patients suffering with cutaneous T-cell 
lymphoma, where 8-methoxypsoralen (8-MOP) in combination with UV-A irradiation was used 
as a treatment therapy.
8
  
There are various examples of naturally occurring light-dependent and light-responsive 
molecules, for example phototropins, a class of light-activated kinases which upon 
photoactivation converts the noncovalent protein-flavin mononucleotide (FMN) complex into a 
covalent protein-FMN adduct within the Per-Arnt-Sim (PAS) domain.
9
 As another example, 
photolyases are involved in the repair mechanism of UV-induced DNA lesions in the genome of 
various organisms such as Escherichia coli, Bacillus firmus, and Saccharomyces cerevisae.
10
  
 
 
6 
 
 
1.3 Irreversible photoregulation of functions of biomolecules  
Photoregulation of DNA properties is usually achieved by covalently attaching a 
photoresponsive molecule to the DNA. Photosensitive molecules, such as caged molecules 
(irreversible photocontrol), and photoswitchable molecules, such as azobenzene, spiropyrans, 
and diarylarenes (reversible photocontrol), have been employed as tools to regulate the functions 
of various biomacromolecules such as DNA, RNA, and proteins.  
1.3.1 Caged photosensitive molecules 
Caged molecules are particularly widely used in photo-control of nucleic acids. J.F. Hoffman 
was the first person to coin the term “caging” in 1978.11 Among the classes of other 
photosensitive or photocleavable molecules, the class of caged molecules emerges as one of the 
most compelling approaches in achieving spatio-temporal control with light as a conditional 
trigger. Caged molecules are photolabile, and are irreversibly cleaved with light, releasing the 
functional molecule.
12
 In 1971 Martinek et al. performed a series of studies on peptidase α-
chymotrypsin (CT).
13
  Reaction of CT 2 with cis-cinnamoyl imidazole 1 resulted in cis-acylated 
product 3 (Scheme 1). α-Chymotrypsin was temporarily deactivated by the formation of cis-
cinnamoylated adduct and this effect persisted for several hours in dark. Upon irradiation with 
light, the cis-product isomerises to trans-adduct 5, regenerating the active enzyme 2, thereby 
cleaving the substrate, tyrosine ester to tyrosine which is then converted to melanin by the 
enzyme tyrosinase. Since only trans- product is cleaved by the enzyme, the cis-cinnamoyl 
product could be called caged.
13
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Scheme 1. Photoreaction of peptidase α-chymotrypsin.
13 
Engels and his group synthesized caged cyclic adenosine monophosphate 7 (cAMP, Scheme 2) 
to investigate the triester’s reactivity towards photolysis in the presence of a photolabile group 
(o-nitrobenzyl group) blocking the terminal phosphate group in cAMP.
14
 The caged cAMP 
showed lower affinity towards protein kinase degradation (protein kinase converts cAMP to 
ADP), however, upon photoirradiation at 366 nm, release of o-nitrobenzyl group due to 
photolysis transforms caged cAMP into active cAMP with high affinity for protein kinase. The 
rate of production of cAMP upon photolysis of caged cAMP was estimated by liquid 
chromatography through the hydrolysis of the triester. A good separation between cAMP and 
open-chain alkyl esters was obtained.  
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Scheme 2. Light-responsive cAMP derivative.
14 
In 1978, Hoffman et al. synthesized the first, caged adenosine triphosphate derivative 10 in 
which the terminal phosphate (Scheme 3) was masked with a photolabile o-nitrobenzyl group.
11 
The caged ATP 10, upon irradiation at 340 nm, underwent photolysis, releasing adenosine 5’-
triphosphate 11. Prior to irradiation, the caged ATP was found to be neither a substrate nor an 
inhibitor of purified renal Na, K-ATPase. Upon illumination at 340 nm, 70% of ATP was 
liberated in 30 s, which was readily hydrolysed to adenosine diphosphate (ADP) and a phosphate 
group (Pi) by Na, K-ATPase. Rapid release of ATP upon photolysis from stable precursor 
renders caged ATP as a stable source of ATP resistant to intracellular ATPases until the ATP is 
released following photolytic irradiation.
11 
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Scheme 3. The first light-responsive molecule 10 to be called caged.
11  
A number of caging chemistries have been used in photoregulation of nucleic acids. Among 
these caging groups, o-nitrobenzyl group (ONB 13, R = H, Figure 4) and its derivatives are 
mostly preferred. ONB is one of the most widely explored protecting groups in solid phase 
reactions as a photocleavable linker.
15 
Despite its wide application as a photolabile group, the use 
in living systems as a caging group is hampered due to the formation of a nitrosoaldehyde 
byproduct of ONB, which is found to be harmful to the body.
16, 17 
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Figure 4. List of photo-labile molecules used as caging groups. (LG= leaving group, carbonate or 
carbamate linker).
15, 18-24 
Figure 4 shows examples of photolabile groups, such as nitrophenylethyl (NPE) 13 (R = Me),
18
 
nitrodibenzofurane chromophore 14,
19
 2-(2-nitrophenyl) propyl (NPP, less harmful nitrostyryl 
species) 15,
20
 coumarin derivative in [7-(dimethylamino) coumarin-4-yl] methyl (DMACM) 
16,
21
 8-bromo-7-hydroxyquinoline (BHQ) 17,
22
 p-hydroxyphenacyl (pHP) 18,
23
 and ketoprofen  
19.
24
 These caging groups have been employed in several studies, to regulate the functions of 
nucleic acids and gene expression.
15
  
1.3.1.1 Regulation of second messenger and nucleotide cofactor functions by 
caged molecules 
Naturally occurring cyclic nucleotides such as cAMP and cGMP (cyclic guanine 
monophosphate) are secondary messengers involved in crucial roles, relaying signals from the 
receptors found on the surface of various cells to the target site inside the cell, such as the 
nucleus.
7
 In addition, cCMP (cyclic cytidine monophosphate) is involved in eukaryotic  
11 
 
 
messaging, whereas the role of cyclic uridine monophosphate (cUMP) is still not clear. cAMP 
was found to play an important role in regulating the turning of growth cones,
25(i)
 which are the 
terminal portions of elongating neurons involved in the rearrangement of the cytoskeleton. It is 
observed that the function of growth cones is sensitive to the cytoplasmic gradient of cAMP. 
Therefore, by controlling the cytoplasmic gradient of cAMP, turning of growth cones can be 
controlled. In this cascade process, netrin-1 acts as first signalling messenger.
25 (ii)
 A recent study 
by Harz et al. showed that controlled release of caged cAMP in the cytoplasm using light 
resulted in spatio-temporal effects on turning of growth cones in chick sensory neurons.
25 (i)
  
Scott et al. used two caged cGMP derivatives (NPE-caged cGMP 20 and water soluble cGMP 
21, Figure 5) to regulate the inward current in cultured dorsal root ganglion (DRG) neurons in 
rat.
26
 The study showed that, in about 12.5% of DRG neurons, rapid activating inward currents 
were aroused due to the activity of cGMP gated channels. In contrast, 52% of DRG neurons 
showed delayed Ca
2+
 dependent inward current through induction of cADP-ribose and 
mobilization of calcium from intracellular stores, due to intracellular release of cGMP. Both 
caged derivatives exhibited delayed inward currents but rapid activating inward current was 
elicited only by NPE-caged cGMP. Therefore this work suggested that cGMP is involved in 
distinct mechanisms to activate inward currents in DRG neurons.  
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Figure 5. Structures of NPE-caged cGMP 20 and the structure of water soluble-caged cGMP 21.
 
Cyclic nucleotide monophosphate (cNMP) was caged by coumarin-based photolabile protecting 
groups and water-soluble derivatives of nitrobenzyl-derived caging groups 22 (Figure 6) by 
Hagen’s group.21, 27 The advantage of these groups is that they allow for fast and efficient 
deprotection and release of cNMPs upon exposure to light. Since the coumarin that is released 
upon deprotection is fluorescent, it helps in detection of percentage of deprotection by 
fluorescence monitoring.  
Nucleotide cofactors, such as nucleotide adenine diphosphate (NADP), were also caged to 
regulate the activity of the enzyme NAD glycohydrolase transglycosidase.
28, 29
 A study 
performed by Salerno et  al.
28, 29
 showed that sterically hindered groups on caged NADP play a 
crucial role in directing the enzymatic transglycosidation of substrate NADP.  
Caged guanosine triphosphate (cGTP) 23 and caged cytidine-5’-diphosphate (cCDP) 24 were 
synthesised (Figure 6).
30 
 cGTP was used to investigate the mechanism of Ras GTPase. Ras is a 
guanine nucleotide binding protein that plays a central role in the transduction of growth signals 
from plasma membrane. It acts as a switch cycling between an active GTP-bound and an inactive 
GDP-bound form. In the GTP-bound form, Ras interacts with its effector Raf.
30
 Binding of the 
effector Raf activates a kinase cascade process, which transduces the external signal to the  
13 
 
 
nucleus via a series of phosphorylation reactions. The effector binding is terminated by 
hydrolysis of protein-bound GTP to GDP. Therefore, the Ras GTPase cascade reaction is 
controlled by regulating the interaction of Ras with GTP by employing caged guanosine 
triphosphate. The unphotolysed cGTP showed no interaction with Ras protein. However upon 
irradiation, cleavage of photosensitive group releases the active GTP which then interacts with 
Ras protein to initiate the cascade reaction.
30
  
                  
Figure 6. Structures of caged cNMP-22,
21, 27
  cGTP 23,
30
 and cCDP 24.
31  
1.3.1.2 Regulation of ribonuclease activities by caged molecules 
Ribonuclease A (RNase A) is an enzyme involved in hydrolytic cleavage of RNA.
32, 33
 However, 
another enzyme from the protease family called subtilisin cleaves a peptide bond of RNase A to 
give RNase S.
32, 33
 The latter ribonuclease comprises two fragments, which are tightly associated 
together: S-peptide (1-20 amino acids) and S-protein (21-124 amino acids).
32, 33 
RNase S 
possesses similar enzymatic activity to that of RNase A.  
14 
 
 
Hamachi et al. 
33
 developed caged ribonucleases by replacing the key amino acids in the α-helix 
region of RNase S with corresponding amino acids with a photolabile o-nitrobenzyl moiety          
(caged lysine 25, glutamic acid 26, aspartate 27, and glutamine 28, Figure 7a).
33
 By 
incorporating photolabile groups at specific locations on RNase S, the RNase S activity was 
suppressed before irradiation. From the study it was observed that positions Q11 and D14 
(Figure 7) were found to be suitable positions for effective caging and suppressing the RNase S 
activity. However the RNase S activity was restored after irradiation.
32, 33 
a) 
                                    
 b) 
                                               
Figure 7.  a) Structures of caged- lysine, glumatic acid, aspartate and glutamine. b) Sequence of caged 
peptide with amino acids bearing caging groups.
33 
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Recently, Wu et al.
34
 reported synthesis of three 20-mer caged circular antisense 
oligonucleotides (R20, R20B2 and R20B4) with a photocleavable linker [1-(o-nitrophenyl)-2-
dimethoxytrityloxy]ethoxy-N,N-diisopropylamino-2-cyanoethoxyphosphine 29 and an amide 
linker between the 10-mer oligodeoxynucleotides (Figure 8). Photo-regulation of RNA-binding 
affinity and ribonuclease H activity were studied with these caged circular antisense 
oligonucleotides. In vitro studies showed that, upon light irradiation, the rate of RNA cleavage is 
greatly enhanced by up to ~ 43-, 25- and 15- fold for R20, R20B2 and R20B4, respectively. The 
presence of linker in R20, and 2- or 4- nt (nucleotides) gaps in R20B2 and in R20B4 affected 
their binding efficiency to the target RNA. The authors
34
 also synthesized three more caged 
circular oligonucleotides (PS1, PS2 and PS3) with 2’-OMe modifications to target green 
fluorescent protein (GFP) expression. Photo-modulation of target RNA hybridization and 
regulation of GFP gene expression in cells were successfully achieved with PS1, PS2 and PS3 
upon light activation. The caged circular antisense oligonucleotides employed in the study 
showed promising photo-modulation of gene expression through both ribonucleases H and non-
enzyme involved antisense strategies.   
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 a)                                                            
 c)                    
 
                        
             
d) PS1-COOH: 5ʹ-HOOCCH2CH2CONH-(CH2)6-CUUGCUCACC-PL-GCUCCUCGCC-
(CH2)6 -NH2-3ʹ.; PS2-COOH: 5ʹ-HOOCCH2CH2CONH-(CH2)6-UUGCUCACCA-PL-AGCUC 
CUCGC-(CH2)6-NH2-3ʹ.; PS3-COOH: 5ʹ-HOOCCH2CH2CONH-(CH2)6-UGCUCACCAU-PL-
AGCUCCUCG-(CH2)6-NH2-3ʹ 
Figure 8. a) Structure of photo-cleavable linker [1-(o-nitrophenyl)-2-dimethoxytrityloxy]ethoxy-N, N-
diisopropylamino-2-cyanoethoxyphosphine, b) Photoregulation of RNA digestion using caged circular 
asODNs and c) Sequences of caged circular as ODNs and complementary target RNA. R20B2 and 
R20B4 have 2- and 4-nucleotide gap in the middle when they bind their target RNA, and d) Sequences of 
photolabile circular antisense oligonucleotides (PS1, PS2, and PS3). 
b) 
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1.3.1.3 Photoregulation of nucleic acid functions using caged molecules 
Caged nucleic acids provide a novel approach to modulate and regulate the functions of nucleic 
acids as well as control of gene expression by incorporating photo-labile groups, which are 
readily removed upon irradiation with light.  
Recently, Deiters and co-workers developed two caged antibiotics using doxycycline 30 and 
toyocamycin 31 to regulate gene expressions.
35 
Caged doxycycline 30 was used to regulate GFP 
expression under the control of the Tet-ON (Tetracycline-Controlled Transcriptional Activation) 
system using light irradiation (Figure 9).
35
 The Tet-ON is a conditional gene control system 
commonly employed in transcription studies in eukaryotic cells. Transcription is reversibly 
turned on or off in the presence of the antibiotic tetracycline or its derivatives (doxycycline). 
Toyocamycin 31 is a natural antibiotic that effectively inhibits ribozyme functions in vivo at 
micromolar concentrations and thus activates gene expression. The study showed that the caged 
toyocamycin 31 was completely inactive and thus did not induce gene expression, however, 
upon exposure to light, the decaged toyocamycin induces spatially restricted activation of gene 
expression of GFP in a monolayer of human embryonic kidney cells.
35
 In the study, the caged 
molecules are attached through covalent bonding to the silencing agent, such as antisense 
oligonucleotides or siRNA (Figure 10a).
35
 In this approach caging molecules are installed on the 
nucleotide bases or on the phosphate backbone, thereby preventing the hybridization of silencing 
oligonucleotides with target mRNA. In another approach, the caging groups are incorporated on 
the complementary hybridising strands in order to prevent the inhibitory action of the antisense 
agent (Figure 10b).
35 
In both cases, the unphotolysed antisense oligonucleotides did not show any  
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antisense activity; however, upon illumination, the liberated antisense oligonucleotides bind to 
the target mRNA, thus affecting the gene expression of GFP.  
 
Figure 9. Light-responsive small molecule regulators of gene expression.  
 
Figure 10. Two different approaches of photoregulation of gene downregulation via antisense agents/ 
RNA interference (S-RNA: small RNA, siRNA: small interfering RNA, PNA: peptide nucleic acid, MO: 
morpholino oligonucleotides, siFNA: small interfering fluoro RNA.  
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Haselton et al.
36
 developed caged plasmid DNAs which encode for luciferase or GFP. The 
plasmid DNAs were caged with the Nv-group 1-(4,5-dimethoxy-2-nitrophenyl)diazoethane 32 
(Figure 11). The caged plasmid DNAs were then introduced into HeLa cells or rat skin cells. In 
both cell lines, the caged plasmid DNA blocked the transcription of GFP. The transcription of 
GFP was restored after irradiating the cells with light (355 nm).  
                                          
Figure 11. The structure of DMNPE caging group on the phosphate backbone of DNA. 
A similar strategy was employed by Okamoto et al.
37
 in developing Bhc-caged (6-bromo-7-
hydroxycoumarin-4-ylmethyl) GFP-mRNA (Scheme 4).  The mRNA was caged with a Bhc-
caging group (as in 33), which upon irradiation with light, released uncaged mRNA. The Bhc-
caged mRNA was injected into zebrafish embryos (one-cell stage). The study showed that the 
Bhc-caged mRNAs effectively inhibit the translation of GFP. Upon irradiation with light, the 
photo-labile group is cleaved, releasing the mRNA 34, thus partially restoring the translational 
activity of mRNA.  
20 
 
 
      
Scheme 4. Caging of RNA with Bhc-diazo and reactivation of the caged RNA by photolysis.
37 
In 2005, Friedman et al.
38
 developed caged small interfering RNA (siRNA). siRNA are short 
double stranded RNA molecules that can downregulate gene expression through the RNA 
silencing pathway.
38
 In this regulatory pathway, siRNAs are first recognised by the RNA-
induced silencing complex (RISC), where one of siRNA strands, the guide strand, hybridises 
with the complementary sequence of mRNA, leading to degradation of mRNA.  
21 
 
 
Caged siRNA strands would inhibit the interaction of siRNAs with the RISC complex or mRNA, 
abolishing RNAi activities. In the study by Friedman et al.,
38
 approximately 1.4 caging groups 
(4,5-dimethoxy-2-nitrophenylethyl, DMNPE) per duplex were introduced into siRNA molecules. 
Silencing of GFP expression in HeLa cell lines was used as a model system. Caged siRNAs 39 
were not completely inactive prior to irradiation, but were fully activated upon irradiation with 
light. The incomplete inactivation of caged siRNA was due to a lower number of caging groups 
(DMNPE) per duplex. siRNAs with an increasing number of caging groups per duplex were 
completely inactive prior to light illumination; however, these siRNAs could not be fully 
activated upon exposure to light. The reason for the incomplete activation of siRNAs was 
insufficient irradiation time to cleave all caged siRNAs into fully active siRNAs. (Scheme 5).
38
  
 
Scheme 5. a) Reaction of siRNA with photo-labile caging group, and b) sequences of target and control 
siRNA used in the study.
38 
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Heckel et al.
39  
introduced caged-deoxyguanosine, dG
c
 41, and caged-thymidine, dT
c
 42 (Figure 
12) into siRNA duplexes at specific site. It was reported that nucleobase modification of siRNA 
at positions close to mRNA cleavage sites (10
th
 and 11
th
 nucleotides) can suppress RNAi 
activity. The caged siRNAs designed in this fashion were found to be completely inactive prior 
to exposure to light (expression of GFP was unaltered); however, after brief exposure (366 nm, 
40 min) to light, RNAi activity was restored, leading to downregulation of GFP expression.
39
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            b) 
                                                                                                                                  
                                                                    
Figure 12.a) Structures of cG
c
, and cT
c
. b) The photolabile caging group masking the Watson-Crick 
interactions between the nucleobases, thus creates a temporary bulge region in the siRNA: mRNA duplex 
of the RISC. Upon irradiation, the photolabile group is completely removed, restoring the Watson-Crick 
base pairing.
39
 
MacMillan et al.
40
 used RNA as a model system to control the function of hammerhead 
ribozymes with light. Hammerhead ribozymes are capable of cleaving RNA via attack of one of 
the 2ʹ-OH groups in the substrate at the adjacent 3ʹ-phosphodiester linkage to form a cyclic  
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phosphate species, leading to the cleavage of the substrate RNA strand.
40
 Since the nucleophilic 
attack of 2ʹ-OH in the substrate is the key step for the cleavage, blocking the nucleophilic attack 
of 2ʹ-OH on the adjacent 3ʹ-phosphate group would allow for the regulation of catalytic activity 
of the ribozyme. RNA with their 2ʹ-OH protected with a photolabile o-nitrobenzyl group (as in 
43, Scheme 6)
40
 showed resistance towards ribozyme prior to exposure to light. Upon exposure 
to light, release of o-nitrobenzyl exposes the 2ʹ-OH group of the substrate 44, which is then 
cleaved by the ribozyme to the same extent as unmodified substrate.  
        
Scheme 6. a) Secondary structure of a hammerhead ribozyme with substrate, b) ribozyme catalysed 
intramolecular transesterification reaction, and c) photo-induced deprotection of 2’-caged hammerhead 
substrate leads to the hammerhead cleavage reaction.
40 
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Modification of nucleobases by caging groups was first shown by Heckel and co-workers.
41, 42
 In 
this work, thymidine was modified at the O4-position with a photolabile o-nitrophenyl-isopropyl 
(NPP) group (as in 46, Figure 13), and then introduced into oligodeoxynucleotides.
41, 42
 The 
caging group acts as a steric block, perturbing the hydrogen bonding capabilities of the base. The 
chemical modification introduced on thymidine was recognised as a mismatch by the T7 RNA 
polymerase, preventing the transcription of the duplex DNA by the T7 RNA polymerase. Upon 
exposure to light, the transcriptional activity of the T7 RNA polymerase was restored to the same 
extent as that of the unmodified DNA. Similarly, the modified guanosine 47 (caged with NPP) 
and the modified cytidine 48 (caged with o-nitrophenylethyl group, NPE) were synthesized.
41, 42
   
        
Figure 13. Structures of caged nucleobases used for light-responsive DNAs.
41,42 
Similar work with RNA bearing caged nucleobases was also demonstrated, using G
NPE
 49,
43
 
U
NPE
 50, A
NPE
 51, and C
NPE
 52
44
 (Figure 14) to modulate the tertiary folding kinetics of RNA 
thereby regulating catalytic and regulatory functions of RNA.  
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Figure 14. Structures of NPE-caged RNA nucleotides.
43, 44 
In work reported by Dmochowski et al.
45
, oligonucleotides bearing caged FRET (Fluorescence 
or Förster Resonance Energy Transfer) pairs were synthesized. In this study adjacent cytidine 
residues were modified with fluorescein and caged Dabsyl (dimethylaminoazobenzenesulfonic 
acid), respectively (as in 53, Scheme 7). Exposure of the oligonucleotide 54 to light led to 
cleavage of the caging group 55, resulting in a 51-fold increase in fluorescence.  
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Scheme 7. Photolysis of oligonucleotides bearing caged FRET pair restoring fluorescence.
45 
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Perrin et al.
46
 synthesized caged adenosine residue 56 to regulate the activity of a DNAzyme 
using light. The C8-position of adenosine was modified with an alkylthioimidazole residue 
(Figure 15). This modification conferred fast and high-yielding cleavage either by homo- or 
heterolysis of the C-S thioether upon exposure to light without leaving any trace of the 
photolabile group on adenosine.
46 
                                                            
Figure 15. Structure of caged adenosine residue.
 
Molecular beacons are short single stranded oligonucleotides that hybridise with target nucleic 
acids in a sequence specific manner. Saito et al.
47
 developed caged molecular beacons to regulate 
the hybridization of single-stranded DNA with its complementary sequences. In this approach, a 
molecular beacon or a single-stranded DNA which forms hairpin stem loop in the absence of 
complementary sequences is modified with a naphthalene quencher at the 5ʹ-end and a photo-
labile pHP (4-hydroxyphenacyl ester) group 57 to which biotin is linked at the 3ʹ-end (Scheme 
8). Upon irradiation with light, no cleavage was observed due to close proximity of quencher and 
photolabile group on the stem loop. The energy is transferred between the photolabile group and 
naphthalene quencher, thus no energy is retained to cleave the photo-labile group. In this system 
the photo-labile group and naphthalene quencher acts as a FRET pair.  
29 
 
 
In the presence of a complementary sequence, the stem loop is opened, and binds to the 
complementary sequence to form duplex DNA, which results in moving the quencher away from 
the p-hydroxyphenylacyl residue. This movement of quencher away from the p-
hydroxyphenylacyl residue allows the cleavage of photolabile group upon the exposure to light, 
releasing the biotin residue 58. 
        
Scheme 8. Photoreaction of a molecular beacon carrying a single stranded DNA in the form of stem loop 
structure. In the absence of target DNA, the quencher blocks the photolysis of photo-liable linker. In the 
presence of the target DNA sequence, the stem loop structure unwinds, moving away from the quencher 
and photo-linker, thus inducing cleavage of the linker.
47 
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1.3.1.4  Photoregulation of gene expression using caging molecules 
Morpholino oligonucleotides (MOs) are synthetic DNA analogues in which the sugar phosphate 
backbone is replaced with morpholino moieties (Figure 16a).
48, 49
 MOs have been found useful in 
inhibiting gene expression in a sequence dependent manner. Morpholino oligomers are widely 
employed in modulation and regulation of gene expression in zebrafish.
34, 49, 50 
The zebraﬁsh is 
ideally suited for this study for visualizing vertebrate ontogeny, because the embryos and the 
larvae of zebrafish are optically transparent and develop rapidly ex utero.
 
Recently, Chen et al.
49
 
developed two caged morpholino oligomers, one with dimethoxynitrobenzyl 59 (DMNB) and 
another with bromohydroxyquinoline (BHQ) (Figure 16b), to regulate the expression of genes 
such as heart of glass (heg), floating head (flh) and endothelial-specific variant gene 2 (etv 2) in 
zebrafish.  
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Figure 16. a) Structure of DNA and Morpholino oligomers. b) i) Structure of DMNB-caged morpholino 
oligomers, ii) Target and inhibitor sequences of heg, flh, and etv2, and iii) Schematic representation of the 
hairpin cMO strategy.
49 
59 
32 
 
 
The intramolecular duplex formed between the morpholino oligomers and the complementary 
inhibitor suppresses the binding of the targeting sequence (morpholino oligomers) with its 
complementary RNA. Upon exposure to light (360 nm), the dissociation of inhibitor allows the 
binding of morpholino oligomer to its complementary RNA, thereby preventing either splicing 
or translation of its RNA target (in this study,
49
 translation of genes heg, flh, and etv2). In a 
similar study, Dieters et al.
51
 reported the synthesis of morpholino oligomers caged with a photo-
labile monomeric building block 60 (Figure 17), and demonstrated the application of the 
oligomer in the regulation of gene function in both cell culture and embryos using light. The 
caged morpholino oligomers were used to inhibit the expression of the EGFP (Enhanced Green 
Fluorescent Protein) in transfected cells, live zebrafish, and Xenopus frog embryos. The 
expression of EGFP was inhibited upon exposure to UV irradiation in both the transfected cells 
and in live embryos of zebrafish and Xenopus frog.  
                         
Figure 17. a) Structure of NPOM caged morpholino oligomer, and b) morpholino sequences used in this 
study.
51 
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Recently, Wu et al.
50
 reported the synthesis of caged circular morpholino oligomers. 
Incorporation of multiple linear caging residues in nucleic acids sterically inhibited the 
interactions between the targeted sequence with its complementary sequence; however, 
incomplete uncaging upon exposure to light was observed. The incomplete uncaging of the 
nucleic acids could be overcome by employing a single caging residue; whereas, the relative 
thermostability of caged- and uncaged-oligonucleotides is difficult to balance, especially in in 
vivo studies.
50
 To overcome these problems, Wu et al.
50
 developed two caged circular 
morpholino oligomers (MO-cat2, MO-ntl), each consisting of a heterobifunctional 
photocleavable linker (PL) (Figure 18), to modulate the expression of the gene β-catenin-2 and 
ntl in zebrafish embryos. The β-catenin-2 gene is essential for the development of dorsal axial 
structures. Knockdown of this gene will cause pin head and truncated pattern defects in the 
embryos. The ntl gene is responsible for the formation of the nodal-independent tail somite. 
Knockout of this gene will result in embryos with missing notochord cells. Caged circular 
moiety cannot hybridise with complementary sequences in mRNA; however upon irradiation 
with light, loss of the caging group restores this ability, leading to annealing with mRNA (Figure 
18). Upon injection of both caged MO-cat2 and MO-ntl oligonucleotides into the embryos of 
zebrafish, gene expression of cat2 and ntl was efficiently photoregulated.
50   
 
 
34 
 
                                              
 
Figure 18.  a) Controlling the gene expression via photolysis of cMO oligomer and subsequent binding to 
target mRNA, b) Sequence of MO-cat2 used in this study.
50
 
Even though the photo-regulation by caging molecules shows promising results and efficient 
photo-control of various bio-molecules, it lacks an important feature, i.e. reversibility, which has 
the advantage of controlling the functions of bio-molecules in a time dependent fashion. Also, 
by-products released from uncaging processes might not be tolerated by living systems. More 
importantly, reversibility renders control of a biomolecule’s function in a multiple-cycle manner. 
In this fashion, no by-products are released in the photoswitching.  
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1.4 Reversible photoswitch molecules 
Despite the advantages of caging technology in achieving clean photo-switch behaviour, 
formation of by-products in stoichiometric amounts during the irreversible reaction severely 
hampers its use as photo-switches. Reversible photoswitch molecules, such as azobenzene, 
spiropyrans, spirooxazines, fulgides, overcrowded alkenes and diarylethenes, can be employed as 
reversible photo-switches to regulate the functions and properties of biomacromolecules such as 
DNA, RNA, and proteins.
7
 These reversible photoswitching molecules are classified into two 
categories based on the thermal stability of their photogenerated isomer:
52
 
1. P-type (photochemically reversible type); these photoswitches do not convert back to the 
initial isomer at elevated temperature (e.g., fulgides and diarylethenes), and 
2. T-type (thermally reversible type); the photogenerated isomer isomerises back to the initial 
isomer thermally (e.g., azobenzenes, stilbenes or spiropyranes). 
1.4.1 Spiropyrans and spirooxazines 
Spiropyrans are photochromic compounds discovered in 1952 by Fischer and Hirshberg.
53
 
Spiropyrans and spirooxazines undergo reversible photo-transformation between two forms upon 
exposure to light, exhibiting two different absorption spectra.
53
 Upon photoisomerization,  not 
only the optical properties but also the physico-chemical properties change, such as refractive 
index, dielectric constant, oxidation/reduction potentials, and geometrical structures.
54
 This 
change in physico-chemical properties can be employed in various optical devices, such as 
erasable optical memory media and photo-optical switch components.  
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Scheme 9 shows a typical photo-reversible reaction of spiropyrans 61 and spirooxazines 63.
53
 In 
this photochromic reaction, the C-O bond undergoes reversible heterolytic cleavage upon UV 
irradiation (360-370 nm), resulting in the formation of a zwitterionic conjugated system known 
as the merocyanine form (62, 64).
53
 This photo-reversible property of spiropyrans has been 
employed in enzymes to confer reversible control on enzyme activity.
53
  
         
Scheme 9. Typical photo-isomerization of spiropyran and spirooxazine.
53 
As an example, Aizawa et al.
53
 employed spiropyran to modulate enzyme activity. Binding of 
trypsin to its inhibitor was photoregulated by appending spiropyran to trypsin inhibitor, a small 
protein.
55 
The photochromic property of spiropyrans has also been employed in the 
photoregulation of proteins. As the function of a protein is directly related to its three-
dimensional structure, perturbation of the protein conformation will lead to changes in its 
activity.
53
 In this regard; the photoisomerization of spiropyrans can be utilized to introduce 
conformational changes to proteins, leading to reversible modulation of protein function. 
56
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Willner et al.
56 
synthesized spiropyran-modified Concanavalin A (Con A), a protein that forms 
complexes with specific pyranoses, such as α-D-mannopyranoside, through a substitutent on the 
imide nitrogen of lysine residues. Binding of spiropyran-modified concanavalin A to the 
substrate, α-D-mannopyranoside 65, was photoregulated. Photoisomerization of spiro-Con-A 66 
to the zwitterionic Con-A 67 resulted in structural perturbation of the Con A, which further 
affected the binding ability of substrates to Con A (Scheme 10).
56
 
        
 
Scheme 10.  Structure of α-D-mannopyranoside and photo-isomerization of spiro-Con-A to zwitterionic 
Con-A.
56 
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1.4.2 Fulgides   
Fulgides were first synthesized by Stobbe in 1905.
57
 Fulgide is the generic name given to 
derivatives of 1,3-butadiene-2,3-dicarboxylic acid (fulgenic acid 68, Figure 19) and 
corresponding anhydride derivatives (fulgide 69).
57
  
                                       
Figure 19. Structures of fulgenic acid and fulgide.
57 
 
The photochromic fulgides contain at least one aromatic ring on the exo-methylene carbon atom, 
which forms a 1,3,5-hexatriene structure that can undergo a 6π-electrocyclization reaction 
(Scheme 11). Fulgides exists in two photochromic forms: one is an open colorless form (E-
form), as the double bond connecting the aromatic ring and the succinic anhydride is usually E-
form 70, and the other is a photocyclized colored C-form 71 (Scheme 11). 
                           
Scheme 11. Typical photo-isomerization of fulgide from E- to C-form.
57 
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Willner et al.
58 
synthesized fulgimide-modified concanavalin A 72 (Figure 20) and α-
chymotrypsin 73 analogues (Figure 20). Fulgimide is attached to the lysine residue of 
concanavalin A. The fulgimide-modified α-chymotrypsin consists of nine fulgimide moieties on 
each protein bound to lysine residues. The structural change of fulgimide induced upon 
photoirradiation affected the binding of 4-nitrophenyl-α-D-mannopyranoside 65 to Con A. The 
association constant of Con A 65 changed from 0.78× 10
4
 M
-1
 for the E-form to 1.21× 10
4
 M
-1
 
for the C-form. Esterification of protein, Con A, on N-acetylphenylalanine in cyclohexane is 
photoregulated by fulgimide.
58                        
                                                 
Figure 20. Structures of E-form fulgide linked concanavalin A, and α-chymotrpsin. 
1.4.3 Diarylethenes 
Diarylethenes are thermally irreversible P-type photochromic compounds.
59 
The most salient 
property of diarylethenes is their resistance towards fatigue. Diarylethenes can undergo 
reversible photoisomerization for more than 10
4
 times without showing fatigue.
59
 Thermal 
irreversibility and fatigue resistance of these compounds make them invaluable tool for optical 
devices such as memory device and photoswitches.
59
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Stilbene 74 is one of the examples of diarylethenes, which undergoes photoisomerization to 
produce dihydrophenanthrene 75. The cyclised dihydrophenanthrene isomerizes back to stilbene 
in de-aerated solution in the dark. However in the presence of air, dihydrophenanthrene 
irreversibly converts to phenanthrene 76 in a reaction with oxygen thereby eliminating a 
molecule of hydrogen (Scheme 12).
59 
           
Scheme 12. The photo-isomerization of stilbene to dihydrophenanthrene and conversion of dihydro- 
phenanthrene to phenanthrene.
 
1.4.4. Overcrowded alkenes 
Overcrowded alkenes are another class of photochromic compounds. Two subclasses of 
overcrowded alkenes are photochromic pseudoenantiomers and enantiomers.
60
 The 
pseudoenantiomers consist of an unsymmetrical upper part (tetrahydrophenanthrene or 2,3-
dihydronaptho(thio)pyran) connected via a double bond to a symmetric lower part (xanthenes, 
thioxanthene, and fluorene).
60
 The molecule adopts a helical shape to avoid steric interactions 
around the central olefinic bond. The photoisomerization of pseudoenantiomers and enantiomers 
is shown in Scheme 13.
60 
Scheme 13b shows a stereospecific photochemical isomerisation 
process that reverses the helicity of the enantiomer thioxanthene alkene using circularly 
polarized light.  
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Scheme 13. a) Photo-isomerization of dissymmetric alkenes; b) photoisomerization of thioxanthene 
alkenes with l-or r-CPL (circularly polarized light).
60 
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CHAPTER 2- Photoisomerization and synthesis of azobenzenes 
2.1 Azobenzene 
One of the most widely used organic chromophores as an optical switch is azobenzene. 
Azobenzene, a T-type photochromic system, displays a reversible photoisomerization process 
between its trans- and cis-isomers. The two forms of azobenzene possess different stabilities and 
absorption spectra.
52
 In the T-type system, photoisomerization causes rearrangement of the 
electronic and nuclear structures of the molecule without any bond breaking. The trans-isomer 
(E, 77) of azobenzene is stable at room temperature, which isomerizes to cis-form (Z, 78, less 
stable) upon exposure to light of a suitable wavelength. The cis-form isomerizes back to trans-
form readily in the dark (Scheme 14).
52, 61 
                            
Scheme 14. E-Z isomerization of azobenzene.
 
The photoisomerization of azobenzene from trans- to cis-form can occur within femtoseconds 
with a strong light source, but the rate at which the cis-form isomerizes back to the trans-form 
mainly depends on the chemical structure of the system.
52 
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Aromatic azo-compounds exhibit a conjugated π system that can be readily tuned through 
appropriate structural modification to adjust chemical and photochemical properties. They have 
thus found wide applications as dyes, pigments, food additives, radical initiators, therapeutic 
agents, as well as functional materials.
61
  
Appropriate structural modification on the azobenzene core results in slow thermal back 
isomerisation of the azo-derivative, which results in a photoactive material valuable for 
information storage (memory) purposes. For azobenzene based photochromic systems to be used 
in real-time information transmitting systems, as well as in optical oscillators, back isomerisation 
to the trans-form (thermally stable form) from the cis-form should occur as fast as possible.
52
 
2.1.1 Photo-isomerization of azobenzene 
The first azo-dye was discovered by Martius in 1863.
62
 In the following years, a wide variety of 
azo-dyes were synthesized and investigated to obtain a dye of desired color and shade which 
could be prepared reproducibly and cheaply.
63
 The existence of the cis-form of azobenzene was 
first demonstrated by Hartley in 1937 using a solvent extraction method.
64
 
Azobenzene has been shown to undergo photo- and thermo-isomerization from the trans-(E) to 
cis-form (Z). The E- and Z-forms oscillate back and forth when excited by light of a selected 
wavelength or by heat (Scheme 14). This reversible photoswitching property can be exploited as 
a useful photoswitch where a signal can be induced by light and harnessed.
61, 65, 66
 One such 
application is incorporation of azobenzene into biomolecules, such as proteins and nucleic acids, 
to trigger conformational changes of the biomolecules that impact their functions.
61, 67-70 
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Figure 21 shows the absorption spectra of azobenzene. The E-azobenzene isomer displays a 
strong absorption band at 318 nm and another weak absorption band at 432 nm. The Z-
azobenzene isomer exhibits a strong absorption band at 260 nm and another weak absorption 
band at 440 nm.
61
 The absorption spectra of the two isomers of azobenzene are distinct but 
overlapping. The absorption band of the trans-isomer shows a weak n-π* band at 432 nm and a 
strong π-π* band at 318 nm. In contrast, the cis-isomer of azobenzene shows a strong n-π* band 
at 440 nm and a weak n-π* band at 260 nm.61 
                                          
Figure 21. UV/Vis absorption spectra of azobenzene 77 and 78 (solid line: Z-isomer; dash line: E-
isomer).
61
 (Reprinted with permission from Zimmerman, G.; L. Y.; Paik, U. J. J. Am. Chem. Soc. 1958, 
80, 3528-3531). 
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2.1.2 Structural features of azobenzene 
The interesting application of azobenzenes lies in its facile and reversible photoisomerization 
about the azo bond, converting between the trans- and cis-geometric isomers. The 
photoisomerization is completely reversible and free from side reactions. Among the two 
isomers of azobenzene, the trans-isomer was found to be more stable at room temperature than 
the cis-isomer by 10-12 kcal mol
-1
 and the energy barrier to the photo-excited state (barrier to 
isomerization) is on the order of 46-48 kcal mol
-1
.  As a result of this stability the trans-isomer is 
dominant (> 99.99%) in the dark at equilibrium.
71, 72, 73 (i)
  
The trans-isomer 77 of azobenzene is nearly planar with nearly zero dipole moment.
73 (ii), 74
 A 
quantitative yield of cis-isomer 78 is obtained upon exposure of trans-isomer to light at 340 
nm.
61, 75
 The cis-isomer of azobenzene possesses a dipole moment of about a 3 debye.
73 (ii)
 The 
distance between the two carbon atoms in the 4- and 4’-positions are 9.0 and 5.5 Å for the trans- 
and cis- isomers, respectively (Scheme 15). The cis-isomer is isomerized back to the trans-form 
either by placing the solution in dark or by irradiation at 450 nm. The photoisomerization of 
azobenzene occurs with moderate quantum yields, where ϕZ-E = 53 % and ϕE-Z = 24 %,
75
 and 
with minimal photo-bleaching. During the photoisomerization process the distance between the 
carbons at the para-positions of the phenyl rings is changed by ~3.5 Å,
73 (ii)
 and this change is 
exploited for applying azobenzene as photoswitch.   
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Scheme 15. Structural changes during the photoisomerization of azobenzene.
73 (ii) 
2.1.3 Mechanism of photoisomerization of azobenzene 
The mechanism of photoisomerization of azobenzene is still controversial and under debate.
76
 
However, recent work on the influence of solvent on the photoisomerization of azobenzene 
suggests that photoisomerization  in azobenzenes can occur through rotation about the -N=N-
bond or by an inversion process involving a rehybridization mechanism about one of the nitrogen 
atoms (Figure 22).
76
 Upon irradiation, the cis- isomer thus formed via inversion or rotation 
mechanism, adopts a bent conformation with its phenyl rings twisted ~ 55
o
 out of the plane from 
the azo group.
61 
 
 
 
 
 
 
 
 
 
N 
N 
9 . 0   Å 
 
N 
N 
5 . 5   Å 
 
U V 
V i s 
77 
78 
trans-form cis-form 
47 
 
              
Figure 22. Photoisomerization pathway from trans-to cis- azobenzene and vice versa.
76 
Changes in structural and physical properties of azobenzenes upon photoisomerization are 
exploited as a valuable tool for the regulation of various functions of nucleic acids.  
 2.2 Synthetic methods for the preparation of azobenzene derivatives 
 2.2.1 Oxidation of primary aromatic amines 
Symmetrical azobenzene derivatives have been prepared through the oxidation of primary 
aromatic amines with oxidizers such as manganese dioxide, potassium permanganate and silver/ 
iodine. Using this approach, azobenzene analogues 81 and 82 were synthesized in 69 and 61% 
yields, respectively, by the oxidation of aniline derivatives 79 and 80 using manganese dioxide in 
hexane under reflux (Scheme 16).
77 
 
48 
 
              
   Scheme 16. Reagents and conditions: a) MnO2, molecular sieves, hexane, reflux. 
Gilbert et al. recently reported the synthesis of azobenzene analogues by treating 4-
chloroaniline 80 with MnO2 in toluene under reflux (Scheme 17).
78
 This approach, however, 
only afforded azobenzene 82 in low yield (49%). Oxidation of para- or meta-halogen 
substituted aniline derivatives 80, 83-85 resulted in the formation of the corresponding 
azobenzene analogues 82, 86-88 in 89, 88, and 79% yields.. 
       
Scheme 17. Reagents and conditions: a) MnO2, toluene, 110 
o
C 
 
Noureldin et al. reported the synthesis of azobenzene derivatives 84, 91, and 92 from aniline 
derivatives 83, 89, and 90 using supported potassium permanganate in 77-78% yield, 
respectively (Scheme 18).
79
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Scheme 18. Reagents and conditions: a) KMnO4, CuSO4·5H2O, CH2Cl2. 
Sodium perborate has also been used in the oxidation of aromatic amines. Abelt et al. reported 
the oxidation of aniline derivative 93 with sodium perborate tetrahydrate in the presence of boric 
acid in acetic acid to give the corresponding azobenzene analogue 94 in 64% yield (Scheme 
19).
80             
 
 
Scheme 19. Reagents and conditions: a) NaBO3·4H2O, B(OH)3, AcOH. 
2.3.2 Reduction of aromatic nitro compounds  
Azobenzene derivatives have been synthesized by the reduction of nitro compounds under 
various conditions, such as using zinc metal under basic conditions, via catalytic transfer 
hydrogenation, treatment with NEt3/Pb and reduction using glucose in a basic medium.
81
 
Recently, Hecht et al. reported the synthesis of azobenzene derivative 95 in 63% yield by 
bromination of methyl-3-nitrobenzoate 96, followed by reduction with zinc metal under basic 
medium (Scheme 20).
82 
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Scheme 20. Reagents and conditions: a) Diacetoxyiodobenzene (DIB), H2SO4; b) Zn, NaOH, aq. EtOH.
82
 
2.3.3 Coupling of primary arylamines with nitroso compounds (Mills reaction) 
Symmetrical azobenzene derivatives can be synthesized by treating aromatic nitroso compounds 
with primary arylamines via the Mills reaction.
83
 In this manner azobenzene analogue 99 was 
obtained in quantitative yield by treating nitroso compound 97 and 98 in acetic acid at 60 
°
C 
(Scheme 21).
84 
        
Scheme 21.  Reagents and conditions: a) AcOH. 
2.3.4 Diazo-coupling via diazonium salts 
One of the most common approaches towards the synthesis of symmetrical azobenzene 
derivatives is to couple diazonium salts with a nucleophilic aromatic compound in an acidic or 
basic medium.
85
 Yang et al. reported the synthesis of azobenzene derivative 100 by treating 
phenol 101 and diazonium compound 102 in sodium acetate (Scheme 22).
86a, 86b
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Scheme 22. Reagents and conditions: a) AcONa.
86 
2.3.5 Oxidation of hydrazo derivatives 
Azobenzene derivatives have also been prepared through the oxidation process of hydrazo 
compounds with H2O2, MnO2, sodium hydroxide, and ferric chloride.
83
 As an example, oxidation 
of hydrazobenzenes 103-105 were effected with pyridinium tribromide and t-BuOCl to give the 
corresponding azobenzene 106-108 in 70% yields. However, selenium containing 
hydrazobenzene 108 was not oxidised with t-BuOCl (Scheme 23).
87 
                              
Scheme 23. Reagents and conditions: a) pyH
+
 Br3
-
, CHCl3; b) t-BuOCl, toluene. 
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2.3.6 Reduction of azoxy derivatives 
Various metals have been employed to deoxygenate azoxybenzene derivatives. Yus et al. 
reported the reduction of azoxy compounds 109 and 110 using NiCl2/Li/DTBB (4,4’-di-tert-
butylbiphenyl) as reducing agents to obtain corresponding azobenzene derivatives 111 and 112 
in 83 and 79 % yields, respectively (Scheme 24).
88 
 
                          
Scheme 24. Reagents and conditions: a) NiCl22H2O, Li, DTBB, THF. 
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CHAPTER-3 Application of azobenzene as a photoswitch 
3.1 Photocontrol of functions of nucleic acids 
The photocontrol of nucleic acid functions is achieved with mainly two approaches: 1) using a 
photo-switchable molecule that can interact with oligonucleotides and 2) tethering a photoswitch 
molecule to the oligonucleotide covalently.  
Recently, Baigl et al.
89
 reported the synthesis of photosensitive cationic surfactants AzoCx 113         
(Figure 23) with varying hydrophobic tail lengths. These surfactants were used as photosensitive 
nucleic acid binders (pNABs) to photo-control the conformation of DNA. The study showed that 
addition of the trans-isomers of various AzoCx compounds resulted in more compact DNA 
compared to their cis-isomers. Increase in hydrophobicity of AzoCx resulted in enhanced ability 
to compact DNA, however this increase in hydrophobicity greatly limited the potential for 
reversible photo-control of conformation of DNA.  
                                                    
Figure 23. Chemical structure of AzoCx.
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In a similar study reported by Baigl et al.
90
 pNABs were used for sequence-independent, 
reversible photo-control of transcription and gene expression. As a pNAB, azobenzene 
trimethylammonium bromide surfactant (AzoTAB) was used. AzoTAB is a cationic surfactant 
with an polar tail which undergoes trans to cis isomerization at 364 nm. This study showed 
photoregulation of binding affinity of AzoTAB with nucleic acids. Binding of AzoTAB to 
nucleic acids resulted in structural changes, and thus affected processes such as transcription and 
translation. It was demonstrated that in vitro production of RNA, expression of GFP, and EGFP 
expression were successfully inhibited in the dark and restored back to normal upon exposure to 
light at 365 nm in the presence of AzoTAB. Changes in the conformation of DNA due to binding 
of AzoTAB upon exposure to light led to structural changes in the DNA recognition sites for 
proteins binding, thereby regulating the gene activity in an efficient, reversible and sequence-
independent manner (Scheme 25).
90 
Addition of AzoTAB resulted in formation of compact 
DNA. This structural change in DNA led to the inhibition of transcription. However, upon 
exposure to UV light, the AzoTAB isomerizes to the cis-form. Due to the bent conformation of 
the  cis- isomer, the AzoTAB cannot stack properly between the nucleobases in the DNA thus 
resulting in the loss of compactness in the DNA. This conformational change in DNA thus 
favours transcription.
90
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Scheme 25. The conformation and transcription activity of genomic DNA is controlled by UV irradiation 
in the presence of the photosensitive condensing agent AzoTAB.
90
  
RNA aptamers are short oligonucleotides of RNA with high specific binding affinity to a target 
molecule. Nakatani et al.
91
 synthesized a short peptide sequence incorporating azobenzene (Lys-
Arg-azobenzene-Arg, KRAzR 116, Figure 24) to photoregulate the binding of RNA aptamers to 
the modified peptide sequence.  
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Figure 24. Chemical structure of photoresponsive peptide KRAzR. KRAzR was immobilised to N-
hydroxysuccinimide (NHS)-activated agarose through the ɛ-amino group of the lysine residue.91  
Upon photoirradiation at 360 nm of KRAzR-immobilized on a gold surface, the binding of RNA 
aptamers to the surface was decreased significantly; however, this binding was restored upon 
exposure to light at 430 nm. When the azobenzene exists in trans-isomer form, but not in the cis-
form, the RNA aptamer’s binding to the surface was induced. From this study a plausible 
secondary structure of aptamers specific to the trans-photoresponsive peptide was identified.
91                     
3.1.1 Photoregulation of DNA hybridization by azobenzene 
DNA hybridization is a natural process where two complementary strands join together to form 
duplex DNA. Nucleic acid hybridization is responsible for genomic rearrangements via both 
homologous and site-specific recombination. Nucleic acid hybridization is a fundamental tool in 
molecular biology to detect specific DNA sequences.  It is also an integral part of processes such  
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as polymerase chain reaction (PCR).  Therefore regulation of nucleic acid hybridization in a 
spatio-temporal fashion will provide more insight into the hybridization process and gene 
expression. One way to achieve spatio-temporal control is by using light.  
Nakatani et al.
92
 reported an approach to photo-control duplex formation of two natural, 
unmodified ssDNA sequences containing a G-G mismatch. In their study, azobenzene was 
modified with a naphthyridine carbamate dimer. The naphthyridine carbamate dimer selectively 
binds to the 5’-CGG-3’/5’-CGG-3’ sequence, which involves a G-G mismatch flanked by two C-
G base pairs. The study showed that the cis-form of the azobenzene derivative favoured the 
hybridization of DNA strands despite of the G-G mismatch. It was noted that hybridization of 
these sequences containing the mismatch did not occur spontaneously in the absence of 
naphthyridine carbamate dimer (Figure 25).
92, 93 
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Figure 25. Photocontrol of duplex formation by modified azobenzene napthathyridine carbamate dimer.
92, 
93
  
In 2007 Komiyama et al.
94 
reported the synthesis of azobenzene tethered to DNA, for the 
photoregulation of duplex formation through trans-cis isomerization of azobenzene. In this 
approach, the azobenzene monomer was synthesized for the incorporation in DNA. Thus, 4-
(phenylazo) benzoic acid 117 was first linked to D-threoninol 118. The resulting D-threoninol 
linked azobenzene was then used to prepare azobenzene phosphoramidite monomer 121 
(Scheme 26).
94
 D-Threoninol, instead of L-threoninol was employed because L-threoninol was 
found to lower the stability of the duplex significantly, even in the trans-form.  
59 
 
 
Azobenzene monomer 121 was installed at any selected position using phosphoramidite 
chemistry-based solid phase synthesis.  
 
 
Scheme 26. Reagents and conditions: a) DCC, 1-hydroxybenzotriazole, DMF, b) DMT-Cl, 4-DMAP, 
pyridine, CH2Cl2, c) 2-cyanoethyl N’,N’,N’,N’-tetraisopropylphosphoramidite, 1H-tetrazole, MeCN, d) 
Incorporation of azobenzene phosphoramidite monomer 121 into oligonucleotides using solid-phase 
synthesis.
94 
Asanuma et al. reported the synthesis of 20-mer oligonucleotides and photo-regulation of DNA 
hybridization through incorporation of nine azobenzene residues. The azobenzene residues are  
 
60 
 
 
intercalated between the adjacent base pairs. Owing to the planar conformation of azobenzene in 
its trans-form, duplex formation is stabilised via base stacking interactions.
94, 95 
Conversely, the 
non-planar conformation of cis-form of azobenzene results in destabilization of the duplex owing 
to steric hindrance, thus favouring dissociation of duplex (Figure 26a).
94
 To achieve efficient 
photoregulation of duplex formation, incorporation of multiple azobenzene units (X) was 
recommended (Figure 26b).  
The percentage of hybridization was quantified using a FRET pair consisting of fluorescein 
(FAM) attached to the 3’-end of the unmodified oligomer and a fluorescent quencher (Dabsyl) 
attached to the 5’-end of the modified oligomer. When the solution containing the azobenzene-
modified strand and its complementary sequence is irradiated with visible light, azobenzene 
adopts the trans-form. Owing to the planar structure of trans-azobenzene, the modified and 
complementary strands are annealed together and thus the fluorescence from the FAM is 
quenched by the Dabsyl.
94
 However, the fluorescence is regenerated when the solution 
containing the azobenzene-modified strand and its complementary sequence was irradiated with 
UV light, due to isomerisation of azobenzene from the trans- to the cis-form. 
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       a) 
                        
       
      b) 
         
Figure 26. a) The photoregulation of DNA hybridization through incorporating azobenzene residues into 
oligonucleotides (X: azobenzene units); b) Sequence of FRET pair used in the incorporation of multiple 
azobenzene moieties.
94 
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In addition, photoisomerisation of azobenzene also affected the melting temperature of DNA 
duplexes. The incorporation of azobenzene units in the oligomer distorted the duplex due to the 
asymmetry of the strands; however the melting temperature was not significantly affected 
because the distortion effect is countered by the increased stacking interactions. 
When the sample containing the azobenzene-modified strand and its complementary sequence 
was exposed to UV light at 37
 o
C, partial isomerization of azobenzene to its cis- form (50%) was 
observed. At temperatures (e.g. 37 
o
C) lower than the melting temperature of the trans-form 
(57.6 
o
C), the photoisomerization from the trans- to cis- form is hindered, due to formation of 
relatively stable duplex. However, when the solution containing the azobenzene-modified strand 
and its complementary sequence was exposed to UV light at 60 
o
C, about 70 % conversion from 
trans to cis was observed, which resulted in approximately 85% dissociation of duplex.
94 
3.1.2 Photoregulation of transcription by T7-RNA polymerase 
T7-RNA polymerase is an enzyme responsible for the synthesis of mRNA from duplex DNA via 
transcription. Tethering azobenzene units to the promoter region of T7-RNA polymerase allows 
reversible photo-regulation of the transcription process. The promoter region of T7-RNA 
polymerase consists of two functional regions: the RNAP recognition region (from -11 and -4 
site, also known as the loop binding region, Figure 27b), and the unwinding region (from -4, and 
-1 site, Figure 27b).
96
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Asanuma et al. introduced azobenzenes into the specific T7 promoter regions, thereby efficiently 
photoregulating the transcriptional activity of T7-RNA polymerase (Figure 27a).
94, 96
 For 
effective photo-regulation of transcription, two azobenzene units are incorporated between the -3 
and -4 sites (unwinding region loop) and between the -9 and -10 sites (loop-binding region) in 
the non-template strand of the T7 promoter region, keeping the template strand intact (Figure 
27b). The experiment was performed below the melting temperature of the trans-form isomer, 
thus the duplex remains intact throughout the photoreaction. However during the 
photoisomerization from trans- to cis-form, the local environment around the duplex is distorted, 
thus affecting the binding mode of the T7-RNA polymerase with the T7-promoter region.
94, 96
  
Upon exposure to visible light, the trans-form suppresses the transcriptional activity of the T7-
RNA polymerase by affecting its binding to the T7-promoter region. The transcriptional activity 
was restored upon irradiation with UV light (Figure 27c). After the UV irradiation the 
transcriptional activity was found to be 7-8 times as fast as after visible-light irradiation. (Figure 
27c).
94, 96 
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              b) 
                       
           c) 
                           
Figure 27. a) Photoregulation of transcription by T7-RNA polymerase using azobenzene tethered DNA, 
b) Sequence design of the photoresponsive T7 promoter and c) Photoswitching of transcription by T7-
RNA polymerase (X : azobenzene units).
94 
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Although azobenzene has been employed as a photoswitch for the reversible photoregulation of 
nucleic acids, the overlapping of absorption spectra of two isomers (Figure 21) has hampered its 
photoisomerization efficiency. To use azobenzene as a photoswitch, one has to switch 
azobenzene back and forth in the S1(nπ
*
) and S2(ππ*) bands. The latter band is located in the 
UV-region, which readily causes damages to biomolecules such as DNA and RNA.
61, 75
 However 
it is possible to derivatize azobenzene to achieve reversible photoswitching without UV- light.
61 
In addition, azobenzene has relatively low quantum yields for direct photoisomerization (trans- 
cis, and cis- trans).
97 
3.2 Cyclic or Bridged Azobenzene 
3.2.1 Photoisomerization of cyclic azobenzene 
Among the many azobenzene analogues known in the literature, the cyclic (“bridged”) 
azobenzene (cAB), 5,6-dihydrodibenzo[c,g][1,2] diazocine compound is of particular interest.
75(i)
 
In cyclic azobenzene, the two phenyl rings are confined with an ethylenic bridge. Conversely 
from azobenzene, in which the trans-form is more stable, the cis-isomer (Z, 123) of cyclic 
azobenzene is more stable compared to trans-isomer (E, 124). Cyclic azobenzene has been 
known for more than 100 years but attracted little attention until very recently, when its potential 
as a molecular photoswitch was discovered by Siewersten et al.
75(ii)
  
The photochromic properties of cAB is much more favourable for photoswitching compared to 
plain azobenzene (AB).
61,75
 The trans-isomer of cAB is switched with blue light (370-400 nm) to 
the cis-isomer with an efficiency >90%, and switched back to cis-isomer in ~100 % efficiency 
with green light (480-550nm)  (Scheme 27).
61, 75
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Scheme 27. Photoisomerization of cyclic azobenzene.
61
 
A UV spectroscopic study of unmodified cyclic azobenzene showed that the trans-isomer 
exhibits a characteristic absorption band with a peak at 404 nm due to its nπ* excitation band.98 
Upon irradiation with blue light at 385 nm, the absorption band at 404 nm almost disappears, and 
a more intense absorption band at 490 nm was observed (Figure 28). The photoisomerization 
quantum yields in the forward and backward directions are 72±4% and 50±10%, respectively.
98
                  
                              
Figure 28. UV/Vis absorption spectra of cyclic azobenzene 123 and 124 (Solid line: (trans or Z)-isomer; 
dash line: (cis or E)-isomer.
61
 (Reprinted with permission from Siewertsen, R.; Neumann, H.; Buchheim-
Stehn, B.; Herges, R.; Näther, C.; Renth, F.; Temps, F. J. Am. Chem. Soc. 2009, 131, 15594-15595).                                   
 
 
         cis-isomer, 123              trans-isomer, 124 
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Efficient photoswitching of cAB in trans-cis and cis-trans directions can be accomplished with 
visible light, contrary to the photo-switching of linear azobenzene that requires irradiation with 
light in the UV region for the trans-cis isomerization. 
The highly efficient photoswitching with a photoconversion yield greater than 90% and 
distinctive absorption bands for trans- and cis- isomers make this molecule a very attractive and 
invaluable tool for designing shape switchable molecules.
99
 
Because of these characteristic properties, a considerable amount of interest has been invested 
towards understanding this new photoswitch, particularly from theoretical point of view.
100, 101 
Like linear azobenzene, the clean photoisomerization property of cyclic azobenzene can also be 
exploited to regulate the nucleic acid functions such as transcription, hybridization, and gene 
expression using light.   
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3.4 Proteins 
Proteins are made up of amino acids covalently linked by polypeptide bonds. Proteins are 
synthesized in vivo in a process called translation. Proteins play diverse roles, such as forming 
cytoskeleton structures, catalyzing metabolic reactions, signal transduction, and transporting 
molecules from one location to another location in multicellular organisms.
102
  
Protein structures are characterized at four levels: primary, secondary, tertiary and quaternary. 
The primary structure of proteins is formed by linear chains of amino acid residues along the 
polypeptide chain.
103 (i)  
Every protein is defined by a unique sequence of amino acid residues and 
all subsequent levels of organization (secondary, tertiary and quaternary) rely on the primary 
structure. Polypeptide chains are organised into secondary structures via hydrogen bonding 
patterns between the backbone peptide bonds.
103 (i)
 The most common types of secondary 
structure are the right-handed α-helix, parallel and antiparallel β-pleated sheets (Figure 29). 
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Figure 29. Graphical representation of primary, secondary (β-sheet and α-helix), tertiary, and quaternary 
structure of protein ("Courtesy: National Human Genome Research Institute"). 
Tertiary structure of a protein is the three-dimensional structure formed by the packing of protein 
secondary structures into compact units.
103 (ii)
 Three-dimensional structures in proteins are 
maintained by ionic bonds, hydrogen bonds, -S-S- bridges, van der Waals forces and 
hydrophobic interactions.
103 (i) (ii)
 The first protein whose tertiary structure was determined is 
myoglobin, an oxygen-binding protein consisting of 153 amino acid residues.
103(i)  
Its structure 
was deduced from X-ray studies by Kendrew, Perutz et al. This study provided not only the first 
three-dimensional representation of a globular protein but also insight into the important bonding  
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modes in tertiary structures.
103(ii)
 Quaternary structure is formed by bringing multiple protein 
subunits into a complex. Subunits are held together by noncovalent forces; as a result, oligomeric 
proteins can undergo rapid conformational changes that affect biological activity.  
The secondary structure of proteins creates unique binding pockets for other biomolecules such 
as DNA and other ligands such as lipids, carbohydrates, flavins, heme group, phosphate group, 
and metal ions. Interaction of proteins with these ligands constructs many aspects of biological 
activity. Therefore, by controlling the conformation of proteins, the interaction between ligands 
and proteins is regulated, thereby affecting a particular function of the protein.  
There is a need to understand more about protein-biomolecule interactions and the role of protein 
conformations in various diseases. Regulation of protein interaction with biomolecules would 
provide more insight into protein functions and their biological roles. Often the conformational 
changes produced in large and complex proteins are small, which makes it more difficult to 
interpret and predict the outcome. Incorporation of light-sensitive molecules into proteins would 
provide a means to regulate protein structures. In addition, reversible control of protein structures 
and functions via photoinduced isomerisation can be achieved by employing reversible 
photoswtiches such as azobenzene.                             
3.4.1 Incorporation of cyclic azobenzene analogues into proteins 
Recently, Woolley at al. reported photocontrol of peptide conformations with a bi-functional 
bridged azobenzene derivative.
104 
 In this study, a thiol-reactive cross linker 132 was synthesized 
from bromonitrobenzyl 125 via p-acetamido substitution. The thio-reactive cross linker was then 
introduced into biomolecules such as peptides and proteins (Scheme 28).
104 
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Scheme 28. Reagents and conditions: a) PPh3, toluene, reflux, 96%; b) t-BuOK, 3-nitrobenzaldehyde 
THF, 0 
o
C RT, 57%; c) H2, Pd/C, MeOH, 90%; d) Ac2O, Py, THF, 78%; e) KNO3, AcOH/H2SO4 (conc.),  
0 
o
C, RT, 31%; f) Ba(OH)2·8H2O, Zn, EtOH, reflux; g) HgO, EtOH, reflux (overall yield for two steps 
8%); h) KOH, MeOH, reflux, 70%; i) chloroacetic anhydride, Py, diethyl ether, 50%. Py = pyridine.
104 
The characteristic photoisomerization of bridged azobenzene was used to control the 
conformation of peptide FK-11, which is known to form a helical conformation in aqueous 
solution. In this peptide, cystine residues were cross-linked intramolecularly with a thiol-reactive 
azobenzene-based photoswitch. Upon exposure to violet light (407 nm), the peptide cross-linked 
with the thiol-reactive species, isomerizes from the cis-form to the trans-form, resulting in an 
increase in helix content.Irradiation with green light (518 nm) resulted in a decrease in helix 
content due to isomerization of the trans- to the cis-form (Figure 30).
104 
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Figure 30. Models showing FK-11 (AcWGEACAREAAAREAACRQ-NH2) crosslinked with 132 in the 
cis (left) and trans (right) conformations.
104 
One of the major problems with this system in an in vivo experiment is the instability of the 
azobenzene inside the cellular environment and its sensitivity to enzymes, such as glutathione, 
which can readily reduce azobenzene.
104 
In the study performed by Woolley et al., the cis-isomer 
was found to be completely stable to overnight incubation with 10 mM reduced glutathione, In 
the contrary the trans-isomer exhibited some photo bleaching in the presence of reduced 
glutathione in a concentration dependent manner.
104
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3.5 Polymers 
3.5.1 Incorporation of azobenzene analogues into polymers 
By attaching a photoresponsive moiety to the polymer, the chemical structure of the polymer 
surface can be modified.
105
 In the past several decades, progress has been made from the 
synthetic, functional design and application of photo-controllable polymers. Among several 
approaches, azobenzene-containing polymers have gained significant interest.  
The characteristic photoisomerization of azobenzene has been used to modulate the chemical 
structure of polymers, which in turn regulates the surface morphology of the polymer.
105, 107-108
 
Several experiments have been carried out to investigate the mass migration phenomenon which 
occurs at the surface of polymer-films containing azobenzene when irradiated with light. 
Eisenbach et al. reported for the first time the reversible photoinduced expansion and contraction 
in an azobenzene containing elastomer.
109
 
Very recently, Ikeda et al.
110
 reported the bending motion of liquid crystals containing 
azobenzene elastomer (Figure 31). In this study, thick liquid crystalline elastomer (LCE) was 
employed to avoid the penetration of UV light to the back of the film. The molecules in the 
elastomer were aligned anisotropically by rubbing. Upon irradiation with light, 
photoisomerization occurs only near the surface of the film on the side of incident light. The 
photoisomerization resulted in shrinkage or expansion of the surface of the film that results in the 
bending motion of the elastomer (Figure 31).
110
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Figure 31. Schematic figure of phototriggered film bending a) homogeneously and (b) homeotropically 
aligned thick film, respectively.  
As shown in Figure 31a,
110
 the deformation of homogeneously aligned LCEs can be induced by 
actinic light, bringing about photomechanical and photomobile properties of LCEs. Upon 
irradiation, photomodulation of LCEs occurs only in the surface region because of the large 
molar extinction coefficient of photochromic LCs. Light cannot penetrate through a thick film 
(thickness > 10μm), and induces the volume change only in the film surface. When the 
alignment of LC molecules is parallel to the surface, volume contraction is observed just along 
the pre-aligned direction, contributing to the anisotropic bending behaviour towards a light 
source. 
In contrary, volume expansion is brought about when the LC molecules are aligned 
perpendicularly to the surface, resulting in different bending behavior away from the light source 
(Figure 31b).
110 
Furthermore, the photomechanical behavior is reversible if azobenzene 
molecules are used as photoresponsive mesogens. By this way light energy can be directly 
transferred into mechanical energy, which attracts much attention in LC research. 
Hu et al.
111
 recently reported azobenzene functionalized hydroxypropyl methylcellulose (AZO-
HPMC 133, Figure 32) polymers and their α-cyclodextrin (α-CD) complexes. Incorporation of 
the azobenzene chromophore into the polymer is confirmed by FT-IR, 
1
H NMR, and FT-Raman  
a 
 
b 
 
75 
 
 
spectroscopies. The study showed that the interaction of α-CD with the side groups of 
azobenzene on AZO-HPMC improved the water solubility of AZO-HPMC polymer. The 
interaction of α-CD with side groups of azobenzene is employed to control the rheological 
properties of the AZO-HPMC polymer.  
                                                              
Figure 32. Chemical structure of hydropropyl methylcellulose.
111 
The AZO-HPMC polymers with varying azobenzene content were prepared by mixing HPMC-
OH 134 and 4-phenylazobenzoyl chloride 135 (Scheme 29).  
          
Scheme 29. Synthesis of AZO-HPMC polymers.
111
  
In the absence of α-CD, the photoisomerization of azobenzene from the trans-form to the cis-
form resulted in an increase in gelation temperature (Figure 33).  
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Figure 33. Sol-gel transition of AZO-HPMC polymer in presence and absence of α-CD. 
The increase in gelation temperature was due to the higher polarity of the cis-form compared to 
that of the trans-form.
111 
In the presence of α-CD, however, opposite results were observed, that is, photoisomerization 
from trans- to cis-azobenzene resulted in a decrease in gelation temperature. Upon 
photoirradiation, the cis-azobenzene is excluded from the α-CD cone, leading to an increase in 
the hydrophobic character of AZO-HPMC/α-CD complex and thus a decrease in the gelation 
temperature (Figure 34).
111 
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Figure 34. Schematic representation of interaction between α-CD and AZO-HPMC polymer in aqueous 
solution.  
3.6 Objectives of the thesis 
The objectives of the thesis work are to synthesize suitably derivatized cyclic azobenzene 
analogues for the incorporation into oligonucleotides, peptides, and polymers. It is anticipated 
that these covalently linked cyclic azobenzene residues will allow for spatiotemporal control of 
the structures, properties, and functions of these macromolecules. Emphasis is placed on the 
incorporation of cyclic azobenzene into oligonucleotides.  
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3.6.1 Synthesis of cyclic azobenzene analogues for the incorporation into oligonucleotides 
In recent years, a significant amount of work has been invested to understand the new 
photoswitch cyclic azobenzene, particularly from the theoretical point of view.
61
 The objective of 
this project was to improve the yield for the preparation cyclic azobenzene from 
2,2’dinitrodibenzyl (4% yield from current synthetic strategy).75(i), 100 Synthesis of cyclic 
azobenzene analogues would allow for further incorporation of this cyclic azobenzene into 
biomolecules. The goal was to synthesize by solid phase DNA synthesis, 20-mer and 35-mer 
oligonucleotides using a carboxyl cyclic azobenzene analogue. The aim was to synthesize 
sequences similar to those employed by Asanuma at al.
94
 in order to compare and contrast the 
effect of photoisomerization of azobenzene and cyclic azobenzene on DNA hybridization, DNA 
melting temperature, and T7-RNA polymerase transcription activity. 
3.6.2 Synthesis of cyclic azobenzene analogues for the incorporation into peptides 
The overall yield for the synthetic strategy developed by Woolley at al. for the synthesis of bi-
functional cyclic azobenzene derivative was less than 10%.
104 
The objective of this project was to 
improve the overall yield for the preparation of bi-functional cyclic azobenzene in fewer 
synthetic steps as compared to the synthetic scheme developed by Woolley at al., which has 9 
synthetic steps. The dicarboxyl cyclic azobenzene analogue will then be incorporated into a short 
peptide using solid phase peptide synthesis. Following the incorporation, the modified short 
peptide sequence will then be used to study the effect of photoisomerization on the conformation 
of modified short peptide.  
3.6.3 Incorporation of cyclic azobenzene analogues into polymers 
79 
 
The objective of this project was to incorporate a carboxyl cyclic azobenzene analogue into a 
polymer (poly(2-hydroxyethyl)methacrylate) to study the effect of cyclic azobenzene 
photoisomerization on the polymer structure and properties. The percentage incorporation of 
cyclic azobenzene will be determined by UV/Vis spectroscopy. The goal was to prepare thin 
films of polymer containing cyclic azobenzene by spin-coating equipment. These thin films will 
be then used to study the effect of photoisomerization on the surface morphology of the polymer 
upon irradiation with light of desired wavelength. The structural changes on the surface of thin 
films of polymers will be studied using scanning electron microscopy. 
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CHAPTER 4- Results and Discussion 
4.1 Synthesis of cyclic azobenzene analogues 
Although a number of approaches were reported for the synthesis of azobenzene from arylnitro-
compounds with high efficiency,
112, 113
 treatment of 2,2’-dinitrodibenzyl 137 under these 
conditions has invariably failed to give the cyclic azobenzene 140 in sufficient yields. 
Cyclic azoxybenzene 140 can also be synthesized from the N-nitrosohydroxylamine ammonium 
salt of 2,2’-dinitrodibenzyl as previously documented (Scheme 30).114 This literature procedure 
was not used in the present study as it necessitates an extra step from a commercially available 
compound. 
 
                    
Scheme 30. Reagents and conditions: a) 5% Rh-C, NH2NH2.H2O, THF, 30 
o
C; b) n-BuO-NO, NH3, Et2O, 
0-10 
oC; c) Δ or hv, EtOH. 
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When 2,2’-dinitrodibenzyl 137 was treated with zinc powder under neutral pH, cyclic hydrazine 
4-(5,6,11,12-tetrahydro-dibenzo[c,g] [1,2]diazocine) 141  (Scheme 31) was formed in moderate 
yields (up to 70%), however, this transformation was found to be highly dependent on the 
surface properties and/or impurity of zinc powder, as use of newer batches of zinc powder only 
gave 141 in very low yields (<5%).                          
Treatment of 2,2’-dinitrodibenzyl 137 with lead metal at pH 9.5 in methanol gave cyclic 
azoxybenzene (11,12-dihydrodibenzo[c,g][1,2]diazocine-5-oxide) 140 in moderate yields (61%) 
(Scheme 31). However the above reaction was found to be dependent on the stirring speed as 
well as the surface properties and/or impurities in metal compound. For larger scale reactions 
(more than 2.00 g), the reaction time spans from 2 to 5 days or even longer. When zinc powder 
was used the reaction time was reduced to 12 h under similar condition (pH 9.5). 
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Scheme 31. Reagents and conditions: (a). Pb, pH 9.5, MeOH, 65%; (b). Zn, pH 7.0, EtOH, 71%; (c). 
TiCl3, aq. HBr, H2O2, 78%; (d). Ph3P, MoCl2O2 (dmf)2, THF, 59%; (e). AlCl3, CS2, 8%; (f). AlBr3, CS2, 
9%; (g). Br2, CH3COOH, 70%; (h). CuCN, DMF, 75%; (i). Al, NH2NH2, 64%; (j) TiCl3, HBr, H2O2, 
MeOH; (k) PCl3, dry benzene, 89%. 
 
The azoxybenzene 140 was subsequently transformed into the corresponding bridged 
azobenzene 142 in 59% yield through catalytic deoxygenation using triphenylphosphine as  
oxygen acceptor in the presence of a molybdenum catalyst.
115, 116
 Structure of the cyclic 
azobenzene 142 was confirmed by X-ray crystallography, where the ethylene bridge is 
disordered over two sets of sites with refined occupancies of 0.552 (14) and 0.448 (14) (Figure 
35a).  
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The azoxybenzene 140 also undergoes concomitant deoxygenation and halogenation when 
treated with aluminium halide (chloride or bromide) in carbon disulfide
117
 to give the 
corresponding chloro 143 or bromo 144 analogues in poor yields (8 and 9% for 143 and 144, 
respectively).  
It was found, however, that azoxybenzene 140 can be brominated with bromine
118
 to give the 
corresponding bromoazoxybenzene 145 (2-bromo-11,12-dihydrodibenzo[c,g][1,2] diazocine- 6-
oxide) in 70% yield. The identity of bromoazoxybenzene 145 was confirmed by its X-ray crystal 
structure (Figure 35b), where two independent molecules with slightly different conformations 
were found in the asymmetric unit.  
 
 
 
 
 
 
Figure 35. The molecular structure of (a) 142 (the dashed lines indicate the bonds of a minor component 
of disorder) and (b) 145 (two independent molecules with slightly different conformations were found in 
the asymmetric unit) with 30% probability displacement ellipsoids (prepared with PLATON).
119 
 
Interestingly, treatment of bromoazoxybenzene 145 with triphenylphosphine and the 
molybdenum catalyst failed to give cyclic bromoazobenzene 144. However, it was found that  
84 
 
 
treatment of 145 with freshly distilled phosphorus trichloride (PCl3) in dry benzene gave the 
corresponding bromoazobenzene 144 in 60% yield.
117
 Cyanoazoxybenzene 146 was obtained in 
69% yield by treating bromoazoxybenzene 145 with copper (I) cyanide.
120
  
Treatment of the latter compound 146 with aluminium and hydrazine hydrate
121
 gave a mixture 
of cyclic cyanoazobenzene 148 and the over-reduced hydrazine 147, with the latter being a major 
product. The hydrazine 147 was further oxidised to the corresponding cyclic cyanoazobenzene 
148 by treatment with titanium (III) chloride, hydrobromic acid and hydrogen peroxide.
122
  
The cyclic cyanoazobenzene 148 was also synthesized by treating 144 with copper (I) cyanide in 
dry dimethylformamide to obtain 148 in 60% yield. Finally, cyclic cyanoazobenzene 148 was 
hydrolyzed under basic conditions to give the corresponding carboxylic acid 149 in 78% yield 
(Scheme 32).  
              
Scheme 32. Reagents and conditions: (a). KOH, EtOH, H2O, reflux, 76%; (b). D-threoninol, DCC, N-
hydroxysuccinimide, DMF, 93%; (c). DMT-Cl, pyridine, 86%; (d). (2-cyanoethyl)-N,N-
phosphochloridite, N,N-diisopropyl ethylamine, THF, 67%; (e). Solid phase DNA synthesis. 
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The cyclic carboxylic analogue 149 was condensed with D-threoninol 150 (D-th) using 
dicyclohexylcarbodiimide as activator in the presence of N-hydroxysuccinimide to obtain D-
threoninol-linked cyclic carboxylazobenzene 151 (D-th-cAB).  
The corresponding DMT-protected D-th-cAB 152 was obtained in 86 % yield by treating 
carboxylazobenzene 151 with DMT-Cl in pyridine. Cyclic azobenzene phosphoramidite 153 was 
synthesized in 67% yield by treating DMT-protected D-th-cAB 152 with the phosphitylation 
agent (2-cyanoethyl) -N,N-diisopropylphosphochloridite in the presence of N.N-diisopropyl 
ethylamine (DIPEA, Hünigs base) in freshly distilled tetrahydrofuran (THF). As expected, this 
amidite consists of two diastereomer as indicated by 
31
P NMR spectroscopy (Figure 36).
 
                                                                      
 
Figure 36. 
31
P NMR of cyclic azobenzene amidite 153. 
31P decoupled 1H 
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4.2 Synthesis of the monomer for the incorporation of azobenzene into DNA 
From the D-threoninol analogue 151, a phosphoramidite monomer analogue was synthesized 
bearing an azobenzene group covalently through an amide bond, as depicted in Scheme 33. Use 
of D-threoninol was important, in particular for subsequent hybridization experiments, because 
L-threoninol significantly lowers the stability of DNA duplexes.
94
 In order to incorporate the 
azobenzene moiety into an oligonucleotide, the D-threoninol functionality is used as a 
substitutent on the sugar group. The distance between two nucleobases in oligonucleotide 155 is 
five bond spaces, as shown in Figure 37. Use of D-threoninol as a linker 156 (Figure 37) exceeds 
the requirement of five bond spaces without destabilising the duplex.
94 
                  
Figure 37. Structures of unmodified and modified oligonucleotides. 
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4.3 Synthesis of oligonucleotides using solid phase DNA synthesizer 
Four steps are involved in the synthesis of DNA via the phosphoramidite method (Scheme 33) 
123  
detritylation, coupling, capping and oxidation. 
 
        
Scheme 33. Chemical steps for the solid phase synthesis oligonucleotides. 
4.4 Photoisomerization study on cyclic azobenzene amide 151 
When the amide 151 was subjected to LED irradiation at either 380 or 400 nm (the LED light 
source spans ± 5 nm), a clear colour change from yellow (the (Z) -isomer) to red (the (E) -
isomer) was observed (Figure 38).
61
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Figure 38. Change in the color of bridged azobenzene 151 during photoisomerization.
 
4.4.1 Study of extent of photoisomerization via HPLC
 
Extents of photoisomerization can be qualitatively determined by HPLC (Figure 39). Figure 39a 
shows the HPLC profile of the trans-isomer of unmodified cyclic azobenzene 142 before 
irradiation with light. As can be seen in Figure 39b, when the unmodified cyclic azobenzene 142 
was subjected to irradiation with LED light at 380 ± 5 nm for 2 h, 90% of the (trans)-isomer was 
converted to the (cis)-isomer (Figure 39b). The extent of the isomerization of 142 is consistent 
with the yield reported in the literature.
75
  
Under the same conditions, approximately 70% of (cis)-isomer of amide 151 was converted to 
the corresponding (trans)-isomer (Figure 39d), whereas Figure 39c shows the HPLC profile of 
cis-isomer of amide 112 before irradiation. The small peak at 13.54 min in Figure 39d shows the 
30% of cis-isomer of amide 151 that did not isomerise into trans-isomer.   
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The reason behind 70% photoisomerization of amide 151 compared to 90% photoisomerization 
of 142 is still unclear but one possible reason could be, absorption of light due to presence of 
amide bond in cyclic azobenzene linked D-threoninol. 
    
Figure 39. HPLC profiles of cyclic azobenzene 142 and 151. (a). (Z)-142; (b). (E)-151; (c). (Z)-151; (d). 
(E)-151. (Profiles a and b: linear gradient of water-acetonitrile (55:45 to 15:85, v/v) over 15 min; profiles 
c and d: linear gradient of water-acetonitrile (90:10 to 55:45, v/v) over 15 min).
61
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4.4.2 Study of extent of photoisomerization using UV/visible spectrometer 
Photoisomerization of 142 and 151 was studied by UV-visible spectrometer in methanol. The 
UV/vis spectra of (Z)-151 and the isomerization product (with an approximate Z/E ratio of 
30:70) are shown in Figure 40a. The small absorption signal (blue line in Figure 40a) at 400 nm 
shows the 30% of (Z)-112 that did not isomerise to (E)-151.  
Compared with the UV/vis spectra of (Z)-142 and the corresponding isomerization product (with 
an approximate Z/E ratio of 10:90) (Figure 40b), the maximal absorption wavelengths for (Z)-
142 and (Z)-151 are the same (at 400 nm), whereas that of (E)-151 shifted from 483 nm for (E)-
142 to 487 nm. Similarly, the small peak at 400 nm (blue line in Figure 40b) shows the 10% of 
(Z)-142 that did not isomerise to (E)-142.       
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Figure 40. UV/vis spectra. (a). (Z)- and (Z)/(E)-142 in methanol (0.60 mM); (b). (Z)- and (Z)/ (E)-151 in 
methanol (1.1 mM).
61 
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4.5 Time course study on photoisomerization of cyclic azobenzene 151 
The time course of (Z)/(E)-151 isomerization was followed by measuring the percentage 
transmission at 480 nm of the methanol solution exposed to 380 nm LED light over time. When 
the solution was irradiated with light at 380 nm using LED, the cis-isomer of 151 isomerizes to 
trans-isomer over time. During this process, the transmission at 480 nm decreases because of the 
increase in the percentage of trans-isomer compared to cis-isomer. Eventually, the transmission 
reaches a minimum (approaches steady transmission reading). In a similar fashion, the trans-
isomer solution was illuminated at 480 nm and the transmission at 480 nm was measured again 
over time.  
During this process, back isomerization of trans-isomer to cis-isomer occurs and the percentage 
of trans-isomer decreases, resulting in an increase in the transmission at 480 nm. As can be seen 
from Figure 41, under this condition, the (Z)/(E) isomerization reached the minimum steady state 
after approximately 40 min, whereas the (E)/(Z) isomerization was slower with a full recovery of 
transmission after approximately 2 h. The back isomerization of 151 from the trans- to the cis-
isomer greatly depends on the chemical architecture of the system (i.e. appropriate modification 
of the substitution on azobenzene core helps to modulate the relaxation rate of azo-compounds). 
The slow back isomerization of trans- to cis-isomer could be due to presence of electron-
withdrawing groups such as carbonyl and amide. It also depends on the mechanism through 
which it undergoes photoisomerization, i.e., either rotation or inversion process.   
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Figure 41.  Isomerization time course of 151 in methanol (0.94 mM) as determined by the percent 
transmission at 480 nm. ♦ : (Z)/(E) isomerization illuminated at 380 nm; ○ : (E)/(Z) isomerization 
illuminated at 480 nm.
61
 Light intensity- 32.3 mW/cm
2
. 
4.6 Conclusion 
Bromo 144-, chloro 143-, cyano 148-, carboxyl 149 and unsubstituted cyclic azobenzene 142 
analogues were synthesised from 2,2’-dinitrodibenzyl 137. Condensation of the carboxyl 
analogue with D-threoninol gave a building block that can be readily isomerised by illumination 
with light. The extent of photoisomerization was quantitatively determined by HPLC. Upon 
illumination with light at 400 nm, approximately 70% of cis- isomer of D-threoninol linked cyclic 
azobenzene was readily isomerised to the corresponding trans-isomer. The UV/vis study has also 
showed approximately 70% isomerisation of cis- isomer to corresponding trans-isomer, which 
correlates to the HPLC data. The time course study showed time dependent isomerisation of the 
cis- to the trans- isomer and trans- to cis- isomer. Cis- isomer was isomerised to trans- isomer in 
approximately 40 min, whereas the trans- to the cis- isomerisation was slower where full 
recovery was obtained after approximately 2h. Cyclic azobenzene phosphoramidite was  
94 
 
 
successfully prepared from DMT-protected D-threoninol linked cyclic azobenzene. Like 
unmodified azobenzene, modified cyclic azobenzene analogues such as carboxyl cyclic 
azobenzene, which showed 70% photo- isomerization efficiency, can be exploited as a useful 
photoswitch. Modified cyclic azobenzene systems are more likely to be tolerated in biological 
systems as irradiation wavelengths are shifted away from the UV region that readily cause 
damage to biomolecules. Future work includes incorporation of cyclic azobenzene into 
oligonucleotides using solid phase DNA synthesizer. 
4.7 Synthesis of bi-functional cyclic azobenzene analogues for incorporation 
into proteins 
Although considerable interest has been invested towards the synthesis and incorporation of 
azobenzene in proteins, synthesis of bi-functional cyclic/bridged azobenzene analogues for the 
incorporation into proteins is relatively new. What has been challenging with this system is poor 
availability of synthetic methods to prepare a bi-functional cyclic azobenzene derivative.  
In this thesis, synthesis of a cyclic azobenzene biscarboxyl acid 162 was undertaken. Treatment 
of 4-(bromomethyl) benzonitrile 157 in dry tetrahydrofuran with manganese slurry, lithium metal 
and naphthalene yielded the corresponding homo-coupling product, dicyanodibenzyl 158 in 44 
% yield (Scheme 34).  
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Scheme 34. Reagents and conditions: (a). MnCl2, lithium metal, naphthalene, THF, 44%; (b). H2SO4, 
HNO3, 72%; (c). Zinc metal, NEt3, HCOOH, pH 7, EtOH, 74%; (d). TiCl3, HBr, H2O2, MeOH, 90%; (e). 
a. KOH, EtOH, H2O, reflux; b. aq. HCl, 73%; (f). Iron nanoparticles, CuBr, H2O, 72%.  
Upon nitration of 158 with nitric acid and sulphuric acid, the corresponding nitro product 
dicyanodinitrodibenzyl 159 was obtained in good yield (70%). The nitro product 159 was then 
reduced to hydrazine 160 with zinc metal in aqueous ethanol (pH 7) in good yield (75%). The 
cyclic hydrazine 160 was then oxidised with titanium chloride, hydrogen bromide and hydrogen 
peroxide in methanol to give cyclic diazine 161 in good yield (84%). Finally the cyclic diazine 
161 was converted to the corresponding final product bi-functional carboxylic cyclic azobenzene 
162 by base hydrolysis with KOH in good yield (70%).  
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The major problem with this synthetic scheme was the poor yield (44%) for the first step with 
manganese metal and lithium metal. Another approach to prepare homo-coupling adduct 158 is 
to use iron nanoparticles (Fe
0
). Recently Taghipoor et al.
124
 reported synthesis of 1,2 
diarylethanes using iron nanoparticles in the presence of Cu(I).  
Following this approach to synthesize a homo-coupling adduct for bifunctional cyclic 
azobenzene, iron nanoparticles were generated by treating ferric chloride with sodium 
borohydride in water solution containing sodium lauryl sulfate. Treatment of 3-nitro-4-
(bromomethyl)benzonitrile 157 with iron nanoparticles (Fe
0
) gave the corresponding homo-
coupled product 158 in moderate yield (50%, Scheme 35).  
This latter synthesis suffers from instability of the iron particles in the presence of oxygen. For 
small scale reactions (50-100 mg), handling of iron nanoparticles was straightforward, however 
with larger scale reactions (more than 100 mg), extreme caution must be taken during handling 
these nanoparticles, which could readily catch fire in air. In addition, over-reduction of 158 to the 
corresponding amine was also observed. Reaction of dicyanodinitrodibenzyl 159 with zinc metal 
to obtain the dicyanohydrazine cyclic azobenzene analogue often lacked reproducibility and 
resulted in over-reduction of the nitro group to the amine due to differences in zinc powder 
batches. When 159 was treated with an older batch of zinc powder under neutral pH, cyclic 
dicyanohydrazine was obtained; however with newer batches of zinc powder, cyclic 
dicyanohydrazine was obtained only twice in ten attempts. This transformation was found to be 
highly dependent on the surface properties and/or impurity of zinc powder.  
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The conventional way of incorporating azobenzene into peptides is shown in Scheme 35. 
                                  
Scheme 35. Incorporation of azobenzene into peptides using Fmoc solid phase peptide synthesis. 
4.7.1 Conclusion 
Bi-functional carboxyl cyclic azobenzene was prepared from 4-(bromomethyl) benzonitrile. 
However synthesis of dicyanodibenzyl from 4-(bromomethyl) benzonitrile poses several 
problems, such as low yield, when 4-(bromomethyl) benzonitrile was treated with magnesium 
slurry, and fire hazard when 4-(bromomethyl) benzonitrile was treated with iron nanoparticles. 
The treatment of dicyanodinitrodibenzyl with zinc metal to obtain the dicyanohydrazine cyclic 
azobenzene adduct lacked reproducibility and often resulted in over-reduction of the nitro group 
to the amine group.  
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Biscarboxyl cyclic azobenzene was not obtained in sufficient quantities to continue with 
incorporation into peptides using a peptide synthesizer. Future work will include optimization of 
the current synthetic scheme to achieve reproducibility and overall good yield. 
4.8 Synthesis and incorporation of cyclic azobenzene analogue into polymer 
In order to explore the impact of cyclic azobenzene on polymer structure and properties, cyclic 
azobenzene carboxylic acid 149 was incorporated into a commercial polymer, poly (2-hydroxy- 
ethyl) methacrylate 163. Poly (2-hydroxyethyl) methacrylate 163 was treated with cyclic 
azobenzene carboxylic acid 149 dissolved in dry chloroform, in the presence of 1-ethyl-3- (3-
dimethylaminopropyl)carbodiimide) (EDC) and a catalytic amount of 4-dimethylaminopyridine 
DMAP (Scheme 36). The reaction was allowed to proceed at room temperature for 24 h and then 
extracted successively with water and chloroform. The chloroform layers were concentrated to 
dryness to obtain the desired product as yellow colored solid 164.  
         
Scheme 36. Synthetic strategy for the incorporation cyclic azobenzene into polymer. 
4.8.1 Determination of incorporation rate by UV/vis spectroscopy 
In order to determine the percentage of incorporation of cyclic azobenzene into the polymer, a 
standard curve of UV absorbance of cyclic azobenzene 149 at various concentrations in 
chloroform at 400 nm was recorded (Figure 42).  
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In order to differentiate the UV absorbance of unreacted azobenzene residue with that of the 
polymer linked azobenzene, the obtained yellow solid was dissolved in dichloromethane (1 ml) 
and triturated with diethyl ether (10 ml). The unreacted cyclic azobenzene partially dissolves in 
diethyl ether. This trituration process is repeated until the diethyl ether layer showed no 
absorbance at 400 nm.  
Percentage incorporation of cyclic azobenzene into the polymer was determined for two polymer 
samples; one sample was taken from the reaction mixture after 10 h and another sample after 24 
h. From UV/vis data (Figure 43) it is observed that the sample collected after 24 h has a higher 
percentage (9%) of incorporation of cyclic azobenzene compared to the sample collected after 10 
h percentage incorporation (6%).        
            
Figure 42. A standard curve of UV absorbance at 400 nm of cyclic azobenzene. 
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Figure 43. UV/vis absorbance at 400 nm of cyclic azobenzene and cyclic azobenzene incorporated 
polymer. 
4.8.2 Conclusions 
Carboxyl cyclic azobenzene analogue was successfully incorporated into the polymer poly (2-
hydoxyethyl)methacrylate. Samples collected after 24 h were found to have approximately 9% of 
incorporation of cyclic azobenzene compared to samples collected after 10 h (percentage 
incorporation 6%). Future work involves establishing the time-dependence of incorporation of 
cyclic azobenzene into the polymer. In addition the changes of the surface morphology of thin 
polymer films upon illumination with light will be studied by confocal microscopy and/or atomic 
force microscopy. 
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4.9 Future Experiments 
(A) Photoregulation of hybridization 
Two unmodified 20-mer sequences, namely 3ʹ-Dabsyl and 5ʹ-FAM and seven modified 3ʹ-
Dabsyl 20-mer sequences with different incorporation of cyclic azobenzene at various locations 
will be used to study the photo-regulation of hybridization. 3ʹ-Dabsyl and 5ʹ-FAM act as a FRET 
pair in this experiment. The experiment involves illumination of solution containing modified 3ʹ- 
Dabsyl and unmodified 5ʹ-FAM sequences. It is hypothesized that in the cis- form of cyclic 
azobenzene, duplex is not formed, due to its non-planar nature. Therefore the fluorescence from 
the FAM is not quenched. However after illumination with light at 400 nm, the cis- form 
isomerizes to trans-form. Owing to the planar geometry of the trans- form, duplex formation will 
be induced. Due to the close proximity of Dabsyl and FAM in the duplex, the fluorescence from 
FAM is quenched by Dabsyl. The percentage fluorescence quenched from FAM will provide 
insight into the efficiency of photoregulation of hybridization by cyclic azobenzene. 
(B) Photoregulation of peptide conformation 
Incorporation of biscarboxyl cyclic azobenzene will be carried out using a conventional peptide 
synthesizer. The modified peptide will then be used study the effect of photoisomerization of 
cyclic azobenzene on peptide conformation and its biological function. 
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(C) Photoregulation of polymer structure and properties 
In future, studies on the time-dependent incorporation of cyclic azobenzene into polymer are 
required to have an understanding on relationship between time and percentage incorporation. 
Incorporating cyclic azobenzene into polymers with different functionalities such as amino 
groups, will also provide insight into reactivity of cyclic azobenzene with different functional 
groups on the polymer. Confocal microscopy and/or atomic force microscopy will be employed 
to study the changes on the surface morphology of thin polymer films with incorporated cyclic 
azobenzene upon illumination with light at desired wavelength.  
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Chapter-5 Experimental 
5.1 Instrumentation 
1
H NMR spectra were measured at 300 or 600 MHz with a Bruker Avance 300 and 600 Digital 
NMR spectrometers with a 14.1 and 7.05 Tesla Ultrashield magnet, respectively.   
Tetramethylsilane was used as an internal standard; 
13
C NMR spectra were measured at 150.9 
MHz and 
31 
P at 121 MHz with the same spectrometer. J values and chemical shifts are given in 
ppm and  Hz, respectively. The following deuterated solvents from C/D/N isotopes Inc. were 
used for the preparation of NMR samples. Dimethyl-d6 sulfoxide with 0.05% tetramethylsilane 
(99.0 atom % D), deuterated chloroform (99.0 atom % D), and deuterated oxide (99.9 atom % 
D).  Low and high resolution mass spectra were obtained with Kratos Concept IS high resolution 
mass spectrometer using electron impact or fast bombardment sources. interfaced with DART 32 
bit acquisition system through a Sun Sparcstation 10 and Mach 3 software. UV/Vis spectra were 
recorded with a Biochrom Ultrospec 2100pro UV/Visible spectrophotometer. Chemicals were 
purchased from Aldrich or TCI America and used without further purification unless stated 
otherwise.  
5.2 Crystal growth 
 Single crystals of cyclic azobenzene 142 and bromoazoxybenzene 145 were obtained by slow 
evaporation of corresponding solutions in absolute ethanol. 
 
 
104 
 
 
5.3 X-ray diffraction experiment  
X-diffraction experiment was performed by Dr. Alan Lough at the University of Toronto. 
Diffraction data were collected on a Nonius Kappa-CCD diffractometer using monochromated 
Mo-K radiation and were measured using a combination of  scans and  scans with  offsets, 
to fill the Ewald sphere. The data were processed using the Denzo-SMN package.
125, 126
 
Absorption corrections were carried out using SORTAV.
126
 The structure was solved and refined 
using SHELXTL V6.1
1280.1
 for full-matrix least-squares refinement that was based on F
2
. All H 
atoms were included in calculated positions and allowed to refine in riding-motion 
approximation with Uiso tied to the carrier atom.  
5.4 Chromatography  
Desican 230-400 mesh silica gel 60 was used for flash chromatography. Thin layer 
chromatography was performed on Silicycle SilicaPlate F-254 TLC plates using the following 
solvent mixtures:  
Solvent A: hexane-dichloromethane (50:50, v/v)  
Solvent B: hexane-dichloromethane (40:60, v/v) 
Solvent C: hexane-dichloromethane (20:80, v/v) 
Solvent D: dichloromethane 
Solvent E: methanol-dichloromethane (5:95, v/v) 
Solvent F: methanol-dichloromethane (10:90, v/v) 
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Solvent G: methanol-dichloromethane-triethylamine (5:94:1, v/v) 
Solvent H: hexane-dichloromethane-triethylamine (48:50:2, v/v) 
Reverse phase high-performance liquid chromatography (HPLC) was carried out on a 4.6 x 150 
mm Acclaim PA C18 3μ column: the column was eluted with water-acetonitrile mixtures at a 
flow rate of 0.80 ml/min. Ion-exchange high-performance liquid chromatography was carried out 
on a DNAPAc column. 
5.5 Solvents and Chemicals 
Benzene and toluene were dried by heating under reflux over sodium in the presence of 
benzophenone for 4 h and then distilled. N,N- Diisopropylamine, dimethylformamide, pyridine, 
and dichloromethane were dried by heating under reflux over calcium hydride for 4 h and then 
distilled. Chloroform was dried by heating under reflux over phosphorus pentoxide for 4 h and 
then distilled.  All the distilled solvents were stored over activated 4 Å molecular sieves. All 
other reagents were purchased from Sigma-Aldrich or VWR Canlab without further purification 
prior to use unless stated otherwise. 
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Preparation of compounds 
11, 12-Dihydrodibenzo[c, g] [1, 2] diazocine-5-oxide 140 
                                                               
Triethylamine (22 ml, 0.16 mol) was added to methanol (100 ml) followed by addition of formic 
acid (5.7 ml, 0.15 mol). The final pH of the solution was adjusted to 9.5. 2,2’-Dinitrodibenzyl 
137 (1.00 g, 3.67 mmol), followed by lead powder (3.50 g, 16.9 mol, 200 mesh) were added. 
After the reaction mixture was stirred vigorously at room temperature for 24 h, another portion 
of lead powder (3.00 g, 14.5 mmol) was added, and stirring was continued for another 24 h. The 
products were filtered and the filtrate was concentrated under reduced pressure. The residue was 
re-dissolved in dichloromethane (20 ml) and extracted with saturated aqueous sodium 
bicarbonate (3 x 10 ml). The organic layer was dried (MgSO4) and concentrated under reduced 
pressure. The residue was purified by column chromatography on silica gel. The appropriate 
fractions, which were eluted with dichloromethane-hexane (40:60 v/v), were pooled and 
concentrated under reduced pressure to give the title compound as a pale yellow solid (505 mg, 
61 %).  
M.p. 167-169 °C (ethanol).  
Rf (system B): 0.49   
HR-MS (EI) found 224.09420, C14H12N2O required 224.09496 
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 δH(CDCl3): 2.88 (1 H, ddd, J = 5.9, 9.6 and 14.4), 2.98 (1 H, ddd, J = 5.2, 10.0, and 14.9), 3.22 
(1 H, ddd, J = 5.1, 10.1, 14.6), 3.37( 1 H, ddd, J = 5.9, 10.1, 15.0), 6.94(1 H, d, J = 7.8), 7.02 (2 
H, d, J = 4.0), 7.04 (1 H, d, J =7.6), 7.10-7.20 (4 H, m).  
δC(CDCl3): 30.1, 31.2, 121.6, 127.2, 127.3, 127.8, 129.6, 130.3, 130.4, 131.5, 131.8, 146.0, 
148.7. 
2-Chloro-11,12-dihydrodibenzo[c,g][1,2]diazocine 143 
                                                             
To a suspension of aluminum chloride (208 mg, 1.56 mmol) in carbon disulfide (3.0 ml), a 
solution of 11,12-dihydrodibenzo[c,g][1,2]diazocine-5-oxide 140 (350 mg, 1.56 mmol) in carbon 
disulfide (2.0 ml) was added drop-wise under nitrogen. The reaction mixture was heated under 
reflux for 5 h and then cooled and concentrated under reduced pressure. To the dark residue was 
added hydrochloric acid (0.1 M, 6 ml), and the mixture was extracted with diethyl ether (3×5 
ml). The organic layers were washed first with water (2×20 ml) and then with saturated aqueous 
sodium bicarbonate (2×20 ml), dried (MgSO4), and concentrated under reduced pressure. The 
residue was purified by column chromatography on silica gel. The appropriate fractions, which 
were eluted with dichloromethane-hexane (30:70v/v), were combined and concentrated under 
reduced pressure to give the title compound as a light yellow solid (30 mg, 8%).  
M.p. 80–82°C (ethanol).  
Rf (solvent C) 0.78.  
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HR-MS (EI) found 242.06156, C14H11ClN2 required 242.06108.  
δH(CDCl3): 2.76 (2 H, m), 2.98 (2 H, br, m), 6.79 (1 H, d, J = 8.4), 6.85 (1 H, d, J = 7.8), 6.99 ( 1 
H, d, J = 1.5), 7.00 and 7.01 (1 H), 7.06 (1 H, t, J = 7.5), 7.11 (1 H, dd, J = 1.9 and 8.4), 7.17 (1 
H, t, J = 7.7).  
δC(CDCl3): 31.4, 31.7, 118.7, 120.4, 126.8, 126.9, 127.4, 127.6, 129.5, 129.7, 130.2, 132.2, 
153.7, 155.3. 
2-Bromo-11,12-dihydrodibenzo[c,g][1,2]diazocine 144 
                                                               
To a suspension of aluminum bromide (145 mg, 0.544 mmol) in carbon disulfide (3.0 mL) a 
solution of 11,12-dihydrodibenzo[c,g][1,2]diazocine-5-oxide 140 (100 mg, 0.446 mmol) in 
carbon disulfide (2.0 ml) was added drop-wise under nitrogen. The reaction mixture was heated 
under reflux for 5 h, and then cooled and concentrated under reduced pressure. The dark residue 
was then treated carefully with hydrochloric acid (0.1 M, 6 ml), and extracted with diethyl ether 
(3×5 ml). The ether layers were combined and washed successively with water (2×20 ml) and 
saturated aqueous sodium bicarbonate (2×20 ml). The organic layer was separated, dried 
(MgSO4) and evaporated to dryness under reduced pressure. The residue was purified by column 
chromatography on silica gel. The appropriate fractions, which were eluted with 
dichloromethane-hexane (30:70 v/v), were combined and concentrated under reduced pressure to 
give the title compound as a light yellow solid (12 mg, 9%).  
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Rf (solvent C): 0.78 
HR-MS (EI) found 286.01081, C14H11BrN2 required 286.01056. 
δH(CDCl3): 2.76 (2 H, m), 2.99 (2 H, br, m), 6.73 (1 H, d, J = 8.4), 6.85 (1 H, d, J = 7.8), 7.02 (1 
H, d, J = 7.5), 7.07 (1 H, t, J = 7.4), 7.15 (1 H, d, J = 1.6), 7.18 (1 H, t, J = 7.5), 7.26 (1 H, dd, J 
= 1.7 and 8.4).  
δC(CDCl3): 31.4, 31.6, 118.7, 120.3, 120.6, 127.0, 127.4, 127.5, 129.7, 129.8, 130.4, 132.4, 
154.2, 155.3. 
5,6,11,12-Tetrahydro-dibenzo[c,g][1,2]diazocine 141 
                                                           
To a solution of triethylamine (2.1 ml, 15 mmol) in ethanol (10 ml) was added formic acid (0.54 
ml, 15 mmol), and the final pH of the solution was adjusted to 7. To this solution was added first 
2,2’-dinitrodibenzyl 137 (100 mg, 0.367 mmol) followed by zinc powder (200 mg, 3.06 mmol) 
over a period of 15 min under vigorous stirring. After the reaction mixture was heated under 
reflux for 5 h, the products were filtered and concentrated to dryness under reduced pressure. 
The residue was extracted with dichloromethane (20 ml). The organic layer was dried (MgSO4) 
and evaporated under reduced pressure. The residue was purified by column chromatography on 
silica gel. The desired product was obtained upon evaporation of appropriate fractions, which 
were eluted with dichloromethane-hexane (35:75, v/v) as a light orange solid (55 mg, 71%).  
Rf(solvent D): 0.70.    
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HR-MS (EI) found 210.11540, C14H14N2 required 210.11570.  
δH(CDCl3): 3.28 (4 H, s), 5.56 (2 H, s), 6.74 (2 H, d, J = 7.9), 6.98 (2 H, t, J = 6.9), 7.13 (2 H, t, J 
= 7.9), 7.19 (2 H, d, J = 6.9).  
δC(CDCl3): 31.4, 117.7, 122.4, 126.6, 131.0, 133.4, 146.6. 
Preparation of molybdenum dioxo dichloride(dmf)2 
                                                            
A stirred mixture of finely powdered molybdenum trioxide (MoO3, 1.00 g, 6.85 mmol) and 10 
ml of 6 M hydrochloric acid was heated under reflux until most of the MoO3 was dissolved          
(about 2-3 h), then cooled to room temperature and filtered. To the filtrate was added freshly 
distilled dimethylformamide (3 ml) under stirring. The resulting white microcrystalline 
precipitate was collected by filtration, washed with acetone (2 ×10 ml) and dried under vacuum. 
The title compound was obtained as light blue powder (2.00 g, 93%). 
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11,12-Dihydrodibenzo[c,g][1,2]diazocine 142 
                                                            
Method A: deoxygenation of azoxybenzene 140 using triphenylphosphine and molybdenum dioxo 
dichloride(dmf)2. To a solution of 11,12-dihydrodibenzo[c,g][1,2] diazocine-5-oxide 140 (100 
mg, 0.446 mmol) in dry tetrahydrofuran (5 ml) were added triphenylphosphine (585 mg, 2.23 
mmol) and molybdenum dioxo dichloride (dmf)2
123, 124
 (20 mg, 5.6 mmol). The reaction mixture 
was heated under reflux for 3 h and then concentrated under reduced pressure. The residue was 
purified by column chromatography on silica gel. The appropriate fractions, which were eluted 
with dichloromethane-hexane (30:70 v/v), were combined and concentrated under reduced 
pressure to give 5,6-dihydrodibenzo[c,g][1,2]diazocine 142 as a light yellow solid (55 mg, 59%).  
Rf (solvent A): 0.72.  
HR-MS (EI) found:  208.10023, C14H12N2 required 208.10005.  
δH(CDCl3): 2,75–2.83 (2 H, m), 2.97–3.05 (2 H, m), 6.85 (2 H, d, J = 7.8), 7.00 (2 H, t, J = 7.5), 
7.03 (2 H, t, J = 7.3), 7.15 (2 H, J = 7.3).  
δC(CDCl3): 31.7, 118.7, 126.7, 127.1, 128.1, 129.6, 155.5 
 
 
 
112 
 
 
Method B: oxidation of hydrazine 141                                                       
To a solution of 5,6,11,12-tetrahydro-dibenzo[c,g][1,2]diazocine 141 (100 mg, 0.476 mmol) in 
methanol (1.5 ml), titanium (III) chloride (5 µl, prepared by diluting 1 ml of ~10 wt.% solution 
of TiCl3 in 20-30 wt.% hydrochloric acid with 10 ml of methanol) and hydrobromic acid solution 
(5 µl, prepared by diluting 1 ml of 33% hydrobromic acid in acetic acid with 10 ml of methanol) 
were added using a Hamilton syringe at room temperature under nitrogen. Hydrogen peroxide 
solution (82 µl, 20% in water, 0.43 mmol) was then added and the reaction mixture was stirred at 
room temperature for 30 min. The volatiles were removed under reduced pressure and the solid 
residue was purified by column chromatography on silica gel. The appropriate fractions, which 
were eluted with dichloromethane-hexane (30:70 v/v), were combined and concentrated under 
reduced pressure to give the title compound as a light yellow solid (45 mg, 45%). NMR data are 
identical to those obtained by method A. 
2-Bromo-11,12-dihydrodibenzo[c,g][1,2]diazocine-6-oxide 145 
                                                           
To a solution of azoxybenzene 140 (100 mg, 0.446 mmol) in acetic acid (1.0 ml), bromine (100 
μl, 1.95 mmol) was added drop-wise. After the reaction mixture was heated at 50°C for 4 h, 
stirring was allowed to continue overnight at room temperature. The products were then diluted 
with cold water (50 ml). Sodium hydrogen sulfite (40% aqueous solution) was added drop-wise 
until the color changed from brown to pale yellow. The mixture was extracted with 
dichloromethane (3×30 ml).  
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The organic layers were combined and washed with water (2×25 ml) and saturated bicarbonate 
solution (2×25 ml). The organic layer was dried (MgSO4) and concentrated under reduced 
pressure. The residue was purified by column chromatography on silica gel. The desired product 
was obtained upon evaporation of appropriate fractions, which were eluted with 
dichloromethane-hexane (40:60 v/v), as a light brown solid (94.5 mg, 70%).  
M.p. 143–146°C (ethanol). 
Rf (solvent C): 0.54.  
HR-MS (EI) found 302.00508, C14H11BrN2O required 302.00547.  
δH(CDCl3): 2.84 (1 H, ddd, J = 5.9, 9.6, and 14.8), 2.98 (1 H, ddd, J = 5.1, 9.9 and 14.8), 3.21 (1 
H, ddd, J = 5.1, 10.1, and 14.8), 3.36 (1 H, ddd, J = 5.9, 9.9, and 15.0), 6.82 (1 H, d, J = 8.4), 
7.07 (1 H, d, J = 7.5), 7.16–7.22 (3 H, m), 7.24–7.26 (2 H, m).  
δC(CDCl3): 30.1, 30.9, 120.5, 121.7, 123.5, 128.1, 129.6, 130.3, 130.6, 131.1, 133.2, 134.1, 
145.0, 148.7. 
2-Bromo-11,12-dihydrodibenzo[c,g][1,2]diazocine 144 
                                                                
To a solution of bromo azoxybenzene 145 (500 mg, 1.65 mmol) in dry benzene, was added 
phosphorus trichloride (2.3 ml, 0.026 mmol) slowly and the reaction mixture was heated under 
reflux for 4 h. The reaction mixture was then evaporated under reduced pressure.  
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To the dark residue, hydrochloric acid (0.1 M) was added, followed by extraction with diethyl 
ether (2×10 ml). The organic layers were washed with sodium bicarbonate (2×10 ml) twice and 
the organic layers were dried (MgSO4) and evaporated to dryness under reduced pressure. The 
residue was purified by column chromatography on silica gel. The desired product was obtained 
upon evaporation of appropriate fractions, which were eluted with dichloromethane-hexane 
(30:70 v/v), as a pale yellow solid (421 mg, 89%).  
Rf (solvent B): 0.78.  
HR-MS (EI) found 286.01081, C14H11BrN2 required 286.01056.  
δH(CDCl3): 2.76 (2 H, m), 2.99 (2 H, br, m), 6.73 (1 H, d, J = 8.4), 6.85 (1 H, d, J = 7.8), 7.02 (1 
H, d, J = 7.5), 7.07 (1 H, t, J = 7.4), 7.15 (1 H, d, J = 1.6), 7.18 (1 H, t, J = 7.5), 7.26 (1 H, dd, J 
= 1.7 and 8.4).  
δC(CDCl3): 31.4, 31.6, 118.7, 120.3, 120.6, 127.0, 127.4, 127.5, 129.7, 129.8, 130.4, 132.4, 
154.2, 155.3. 
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2-Cyano-11,12-dihydrodibenzo[c,g][1,2]diazocine-6-oxide 146  
                                                          
To a solution of 2-bromo-11,12-dihydrodibenzo[c,g][1,2] diazocine-6-oxide 145 (100 mg, 0.330 
mmol) in dry N,N-dimethyl formamide (3.0 ml), copper (I) cyanide (40 mg, 0.447 mmol) was 
added. After the reaction mixture was heated under reflux overnight, the products were cooled to 
room temperature, followed by addition of ethylenediamine (10% aqueous solution, 15 ml) the 
mixture was extracted with dichloromethane (2×20 ml). The organic layer was separated and 
successively washed with sodium cyanide (10% aqueous solution, 10 ml) and water (3×20 ml). 
The organic layer was dried (MgSO4) and concentrated under reduced pressure. The residue was 
purified by column chromatography on silica gel. The desired product was obtained upon 
evaporation of appropriate fractions, which were eluted with dichloromethane-hexane (60:40 
v/v) as a pale yellow solid (62 mg, 75%).  
M.p. 178–181°C (ethanol).  
Rf (solvent C): 0.32.  
HR-MS (EI) found 249.08949, C15H11N3O required 249.09021.  
δH(CDCl3): 2.94 (1 H, ddd, J = 5.3, 10.0, and 14.8), 3.02 (1 H, ddd, J = 4.8, 10.1, and 14.8), 3.26 
(1 H, ddd, J = 4.6, 10.3, and 14.7), 3.40 (1 H, ddd, J = 5.2, 10.0, 14.8), 7.05 (1 H, d, J = 8.2), 
7.07 (1 H, d, J = 7.5), 7.17 (1 H, d, J = 7.6), 7.22 (1 H, t, J = 7.4), 7.25 (1 H, d, J = 7.4), 7.35 (1 
H, s), 7.43 (1 H, d, J = 8.1).  
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δC(CDCl3): 29.9, 30.7, 111.0, 118.1, 121.6, 122.8, 128.3, 129.8, 130.7, 131.0, 131.3, 133.8, 
134.2, 148.6, 149.5. 
5,6,11,12-Tetrahydrodibenzo[c,g][1,2]diazocine-2-carbonitrile 147 
                                                               
To a solution of 2-cyano-11,12-dihydrodibenzo [c,g][1,2]diazocine-6-oxide 146 (100 mg, 0.401 
mmol) in methanol (3.0 ml), hydrazine hydrate (0.5 ml, 16 mmol) and aluminum powder (200 
mg) were added. After the reaction mixture was heated under reflux for 24 h, the products were 
filtered through a thin layer of celite and washed with dichloromethane (10 ml). The filtrate and 
washing were combined and concentrated under reduced pressure. The residue was purified by 
column chromatography on silica gel. The desired product was obtained upon evaporation of 
appropriate fractions, which were eluted with ethyl acetate-hexane (20:80 v/v), as a pale yellow 
solid (60 mg, 64%).  
Rf (solvent D): 0.43.  
HR-MS (EI) found 235.11045, C15H13N3 required 235.11095.  
δH(DMSO-d6): 2.97–2.99 (2 H, m, br), 2.31–2.34 (2 H, m, br), 6.84 (1 H, dt, J = 1.0 and 7.3), 
6.86 (1 H, d, J = 8.2), 6.87 (1 H, d, J = 7.3), 7.03 (1 H, dt, J = 1.2 and 7.4), 7.08 (1 H, d, J = 7.2), 
7.26 (1 H, d, J = 4.3), 7.43 (1 H, dd, J = 1.9 and 8.3), 7.48 (1 H, d, J = 1.5), 7.93 (1 H, d, J = 
4.3).  
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δC(DMSO-d6): 30.2, 31.3, 101.0, 116.3, 118.4, 120.5, 121.9, 126.7, 130.7, 131.2, 132.5, 132.8, 
134.6, 147.8, 153.3. 
11,12-Dihydrodibenzo[c,g][1,2]diazocine-2-carbonitrile 148  
                                                               
To a solution of 5,6,11,12-tetrahydrodibenzo[c,g][1,2] diazocine-2-carbonitrile 147 (110 mg, 
0.468 mmol) in methanol (2 ml), titanium (III) chloride (5 µl, prepared by diluting 1 ml of ~10 
wt.% solution of TiCl3 in 20-30 wt.% hydrochloric acid with 10 ml of methanol) and 
hydrobromic acid solution (5 µl, prepared by diluting 1 ml of 33% hydrobromic acid in acetic 
acid with 10 ml of methanol) were added using a 10 µl Hamilton syringe at room temperature 
under nitrogen. After a solution of hydrogen peroxide (100 µl, 20% in water, 0.526 mmol) was 
added drop-wise at room temperature, the reaction mixture was stirred at room temperature for 
15 min. The volatiles were removed under reduced pressure and the solid residue was purified by 
column chromatography on silica gel. The appropriate fractions, which were eluted with 
dichloromethane-hexane (55:45 v/v), were combined and concentrated under reduced pressure to 
give the title compound as a light yellow solid (85 mg, 78%).  
Rf (solvent D): 0.60.  
HR-MS (EI) found 233.09554, C15H11N3 required 233.09530.  
 
 
118 
 
 
δH(CDCl3): 2.78–2.87 (2 H, m), 3.00–3.07 (2 H, m), 6.87 (1 H, d, J = 7.7), 6.92 (1 H, d, J = 8.1), 
7.01 (1 H, d, J = 7.5), 7.08 (1 H, dt, J = 1.2 and 7.5), 7.19 (1 H, t, J = 7.5), 7.32 (1 H, d, J = 1.2), 
7.44 (1 H, dd, J = 1.4 and 8.0).  
δC(CDCl3): 31.9, 110.8, 118.2, 118.6, 119.5, 127.0, 127.2, 127.8, 129.9, 130.1, 130.7, 133.5, 
155.3, 158. 
11,12-Dihydrodibenzo[c,g][1,2]diazocine-2-carboxylic acid 149 
                                                            
The carbonitrile 148 (100 mg, 0.429 mmol) was placed in a solution of potassium hydroxide 
(2.65 g) in ethanol (25 ml) and water (10 ml) and heated under reflux for 4 h. The solvents were 
removed under reduced pressure and the residue was treated with aqueous hydrochloric acid (6 
N) until the mixture turned acidic (pH 4). The mixture was extracted with ethyl acetate (3×20 
ml). The combined organic layers were washed with brine (2×10 ml), dried (MgSO4), and 
concentrated under reduced pressure to give the crude carboxylic acid which was purified by 
column chromatography on silica gel. The appropriate fractions, which were eluted with 
dichloromethane-methanol (95:5 v/v), were combined and concentrated under reduced pressure 
to give the title compound as a light yellow solid (82 mg, 76%).  
Rf (solvent E): 0.60. 
HR-MS (EI) found 252.08979, C15H12N2O2 required 252.08988.  
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δH(CDCl3): 2.83 (1 H, m), 2.89 (1 H, m), 3.04 (2 H, m), 6.87 (1 H, d, J = 7.8), 6.92 (1 H, d, J = 
8.1), 7.00 (1 H, d, J = 7.6), 7.05 (1 H, t, J = 7.7), 7.17 (1 H, t, J = 7.5), 7.76 (1 H, d, J = 1.2), 7.87 
(1 H, dd, J = 1.3 and 8.1).  
δC(CDCl3): 31.4, 31.5, 118.6, 118.8, 127.0, 127.4, 127.5, 127.6, 128.9, 129.9, 131.8, 155.4, 
159.8, 169.9. 
(Z)-N-((2S,3S)-1,3-Dihydroxybutan-2-yl)-11,12-dihydrodibenzo [c,g][1,2] 
diazocine-2-carboxamide 151 
                                                    
To a solution of 11,12-dihydrodibenzo[c,g][1,2]diazocine-2-carboxylic acid 149 (100 mg, 0.397 
mmol) in dry N,N-dimethyl formamide (2.0 ml), D-threoninol 150 (35 mg, 0.33 mmol), N,N-
dicyclohexylcarbodiimide (82 mg, 0.40 mmol) and N-hydroxysuccinamide (46 mg, 0.40 mmol) 
were added. After the reaction mixture was stirred for 5 h at room temperature under a nitrogen 
atmosphere, the precipitate was removed by filtration and the filtrate was evaporated under 
reduced pressure. The oily residue was purified by column chromatography on silica gel. 
Evaporation of appropriate fractions, which were eluted by dicholoromethane-methanol (95:5 
v/v), gave the title compound as a pale yellow foam (105 mg, 93% based on D-threoninol).  
Rf (solvent F): 0.7.  
[α]D
20 
= -12.8 (c = 0.10, methanol).  
HRMS (EI) found 339.1569, C19H21N3O3 required 339.15829.  
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δH (DMSO-d6): 1.01 (3 H, t, J = 6.1), 2.83-2.86 (2 H, m), 2.88-2.91 (2 H, m), 3.40-3.45 (1 H, m), 
3.51-3.55 (1 H, m), 3.81-3.84 (1 H, m), 3.85-3.88 (1 H, m), 4.56-4.61 (2 H, m, br, OH, ex), 6.88 
(1 H, d, J = 7.8), 6.92 (1 H, d, J = 8.1), 7.07 (1 H, t, J = 7.3), 7.10 (1 H, d, J = 7.2), 7.19 (1 H, dt, 
J = 7.19) (1 H, t, J = 7.2), 7.60 (1 H, d, J = 2.9), 7.66 (1 H, d, J = 8.1), 7.71 (1 H, d, J = 8.3, NH, 
ex).  
δC (DMSO-d6): 20.6 and 20.7, 31.2 and 31.4, 57.2, 60.7 and 60.9, 65.3, 118.6 and 118.7, 118.8, 
126.5 and 126.6, 127.4, 127.8, 128.1, 128.5 and 128.6, 129.5 and 129.6, 130.4, 133.8, 155.6, 
157.5, 166.1. 
(Z)-N-((2R,3S)-1-(bis(4-methoxyphenyl)(phenyl)methoxy)-3-hydroxybutan-2-
yl)-11,12-dihydrodibenzo[c,g][1,2]diazocine-2-carboxamide 152 
                                  
(Z)-N-((2S,3S)-1,3-Dihydroxybutan-2-yl)-11,12-dihydrodibenzo[c,g][1,2]diazocine-2-
carboxamide  151 (700 mg, 2.06 mmol) was azeotroped with dry toluene (10 ml) and then dry 
pyridine (2 × 10 ml). To the reaction flask containing 151, dry pyridine (20 ml) was added and 
the mixture was azeotroped to a volume of approximately 10 ml. To the solution, 4,4’-
dimethoxytrityl chloride (840 mg, 2.47 mmol) was added under nitrogen. The reaction mixture 
was stirred at room temperature for 1 h and triethylamine (1 ml) was added. The products were 
poured into saturated aqueous sodium bicarbonate (40 ml) and extracted with dichloromethane 
(3× 30 ml).  
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The organic layers were combined, dried (MgSO4) and evaporated to dryness to obtain an oily 
product. The oily residue was purified by column chromatography on silica gel. The desired 
product was obtained upon evaporation of appropriate fractions, which were eluted with 
methanol-dichloromethane (1:99 v/v), as a pale yellow foam (1.133 g, 86 %).  
Rf (solvent G): 0.65  
LRMS (ESI) found 640.30 (M-H
+
), C40H30N3O5 required 641.29.  
δH (DMSO-d6): 0.974 (3 H, d, J = 6.0), 2.85-2.93 (5 H, m). 3.14-3.19 (1 H, m), 3.7 (6 H, d, J = 
1.5), 3.9-4.0 (2 H, m), 4.52-4.55 (1 H, d, J = 3), 6.8-7.9 (20 H, m), 8.01-8.03 (1 H, m, NH, ex) 
δC (DMSO-d6): 20.7 and 31.1 and 31.4 and 55.3, and 55.4, 55.6 and 55.7 and 63.3 and 63.5, 65.6 
and 65.6, 85.5, 113.5 and 118.7 and 118.7, 126.5, 126.9, 127.3, 127.8, 128.1, 128.1, 128.5, 
128.6, 129.5, 129.6, 130.0, 130.1, 130.1, 130.3, 133.6 and 133.7, 136.1, 136.2, 136.3, 136.4, 
145.5, 155.5, 157.5, 158.4, 166.0 and 166.1.  
2-cyanoethyl-phosphodichloridite  
                                                        
3-Hydroxypropionitrile (54.0 ml, 0.79 mol) and 1,1,1,3,3,3-hexamethyldisilazane (84.0 ml, 0.40 
mol) were mixed and heated at 135 
o
C. After 2 h, the products were cooled to room temperature. 
Dry acetonitrile (500 ml) was added, and this solution was added dropwise to a solution of 
phosphorus trichloride (75.0 ml, 0.86 mol) in acetonitrile (800 ml) at -40 
o
C over a period of 2h. 
After the addition was complete, the reaction mixture was allowed to warm up to room 
temperature over a period of 2 h.  
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The products were then concentrated under reduced pressure. The viscous liquid was distilled 
under vacuum (90 
o
C/1 mmHg) to give the title compound as a colorless liquid (67.1 g, 98%). 
 δp [D2O insert]: 178.3. 
(2-cyanoethyl)-N,N-diisopropyl phosphochloridite 
                                                        
Dry diisopropylamine (40.75 ml, 0.29 mol) in dry diethyl ether (80 ml) was added dropwise to a 
solution of 2-cyanoethyl phosphodichloridite (25.0 g, 0.145 mol) in dry diethyl ether (350 ml) at 
-20 
o
C over a period of 2h. After the addition was complete, the reaction mixture was allowed to 
warm up to room temperature and stirring was continued for another 20 h. The products were 
filtered by cannular filtration and the filtrate was concentrated under reduced pressure. The 
viscous liquid was then distilled under vacuum  (140 
o
C/1 mmHg) to give the title compound as a 
colorless liquid (31.4 g, 91%). δp [D2O insert]: 177.7 
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(2S,3R)-4-dimethoxytrityl-3-((Z)-11,12-dihydrodibenzo[c,g][1,2]diazocine-2-
carboxamido)butan-2-yl(2-cyanoethyl) diisopropylphosphoramidite 153 
                                          
1-O-Dimethoxytrityl-3-hydroxybutan-2-yl)-11,12-dihydrodibenzo[c,g][1,2]diazocine-2-
carboxamide 152 (572 mg, 0.892 mmol) was azeotroped with dry toluene (2×10 ml) and 
dissolved in dry tetrahydrofuran (5 ml), followed by addition of dry N,N-diisopropyl ethylamine 
(Hünigs base, DIPEA, 0.5 ml, 2.67 mmol), and (2-cyanoethyl)-N,N-diisopropyl 
phosphochloridite (314 mg, 1.33 mmol). The reaction mixture was stirred at room temperature 
for 30 min. Triethylamine was added and the products were evaporated under reduced pressure. 
The residue was purified by column chromatography on silica gel. The desired product was 
obtained upon evaporation of appropriate fractions, which were eluted with hexane-
dichloromethane-triethylamine (28:70:2 v/v), as a pale yellow color glass (500 mg, 67%).  
Rf (solvent H): 0.57 
LRMS (ESI) found 876.40 [M
+
Cl
-
] C49H56N5O6P required 876.37.  
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δH (CDCl3): 1.14-1.28 (15 H, m), 2.30 (1 H, s), 2.56-2.57 (2 H, m), 2.66-2.67 (2 H, m), 2.80-2.85 
(2 H, s), 3.01 (2 H, s), 3.18 -3.27 (2 H, m), 3.50 (3 H, s), 3.78 (6 H, s), 4.32-4.44 (2 H, m), 6.40-
6.46 (1 H, m, NH ex), 6.79-7.50 (20 H, m).  
δC(CDCl3): 10.9, 11.4, 14.1, 18.7, 19.7, 20.2, 20.2, 20.4, 20.7, 22.6, 24.3, 24.4, 24.5, 24.6, 24.7, 
25.2, 29.0, 29.7, 31.4, 31.5, 31.6, 31.7, 34.5, 34.6, 36.0, 43.0, 43.1, 43.2, 46.1, 53.4, 54.4 and 
54.48, 54.8, 55.1, 55.2, 57.7, 57.8, 58.1, 58.2, 62.7, 62.9, 69.0, 69.1, 86.1, 86.2, 113.1, 113.2, 
117.6, 117.7, 118.6, 118.9, 125.0, 125.1, 125.2, 126.7, 126.8, 126.9, 127.3, 127.4, 127.5, 127.8, 
127.9, 128.1, 128.2, 128.8, 128.9, 129.0, 129.1, 129.8, 130.0, 130.1, 133.2, 133.3, 135.9, 136.0, 
144.7, 155.3, 155.4, 157.7, 158.4, 166.2. 
δp [CDCl3]: 148.19 and 148.22 
4,4'-(ethane-1,2-diyl)dibenzonitrile 158 
                                                       
To a solution of anhydrous manganese chloride (202 mg, 1.6 mmol) in dry tetrahydrofuran (3 
ml), naphthalene (45 mg, 0.33 mmol) and lithium metal (22.2 mg, 3.2 mmol) were added. The 
reaction mixture was stirred at room temperature for 1 h followed by addition of 4-
(bromomethyl)benzonitrile 157 (250 mg, 1.275 mmol). Stirring was continued for 20 min at 
room temperature and then hydrochloric acid (3 N) was added until evolution of fume stopped. 
The products were extracted with ethyl acetate (2×15 ml). The organic layer was washed with 
saturated sodium bicarbonate (2×15 ml), dried (MgSO4) and purified by column chromatography 
on silica gel.  
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The appropriate fractions, which were eluted with hexane-ethyl acetate (90:10 v/v), were 
combined and concentrated under reduced pressure to give the title compound as a light yellow 
solid (65 mg, 44 %).  
Rf (solvent B): 0.63 
HRMS (EI): found 232.10005, C12H12N2 required 232.1000 
δH (CDCl3): 3.01 (4 H, s), 7.23 (4 H, d, J = 8.1), 7.58 (4 H, d, J = 8.4) 
δC (CDCl3): 37.2, 110.3, 118.8, 129.1, 129.2, 130.0, 132.3, 146.0 
4,4'-(ethane-1,2-diyl)bis(3-nitrobenzonitrile) 159 
                                                             
To a solution of 4,4’- (ethane-1,2-diyl) dibenzonitrile 158 (115 mg, 0.50 mmol) in sulfuric acid 
(2 ml), conc. nitric acid (2 ml) was added slowly at 0 °C. The reaction mixture was stirred at 0 
°C for 1 h, followed by addition of cold water (10 ml) and then extracted with dichloromethane 
(2× 10 ml). The organic layers were combined, washed with saturated sodium bicarbonate, dried 
(MgSO4), concentrated under reduced pressure, and purified by column chromatography on 
silica gel. The appropriate fractions, which were eluted with hexane-dichloromethane (60:40, 
v/v), were combined and concentrated under reduced pressure to give the title compound as a 
light yellow solid (115 mg, 72 %).  
Rf (solvent B): 0.70 
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LRMS (FAB): found 391.0 [M
 
+ 3 Na
+
] C16H10N4O4 required 391.0 
δH (CDCl3): 3.34 (2 H, s), 7.64 (1 H, d, J = 8.1), 7.81-7.90 (1 H, dd, J1,2 = 1.5, J1,3 = 8.1), 8.31 (1 
H, s). 
δC (CDCl3): 34.3, 112.6, 116.7, 117.5, 128.8, 133.6, 136.2, 140.2. 
5,6,11,12-tetrahydrodibenzo[c,g][1,2]diazocine-3,8-dicarbonitrile 160 
                                                         
To a solution of triethylamine (2.1 ml, 0.015 mol) in ethanol (7 ml) was added formic acid (0.54 
ml, 0.014 mol) and the final pH of the solution was adjusted to 7. To this solution was added 
4,4'- (ethane-1,2-diyl)bis(3-nitrobenzonitrile) 159 (100 mg, 0.310 mmol) followed by zinc 
powder (200 mg, 3.05 mmol) over a period of 15 min under vigorous stirring. The reaction was 
stirred at room temperature for 5 h. The products were filtered, concentrated under reduced 
pressure. To the residue, saturated aqueous sodium bicarbonate (20 ml) was added and extracted 
with dichloromethane (2×25 ml). The organic layers were combined, dried (MgSO4) and 
concentrated under reduced pressure. The residue was purified by column chromatography on 
silica gel. The appropriate fractions, which were eluted with dichloromethane-hexane (50:50 
v/v), were pooled and concentrated under reduced pressure to give title compound as a pale 
yellow solid (60 mg, 74.2 %). 
Rf (solvent C): 0.60 
LRMS (EI): found 260.0 C16H12N4 required 260.0 
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δH (DMSO-d6): 3.11 (2 H, s), 7.18 (1 H, d, J = 1.5), 7.23- 7.31 (2 H, m), 7.67 (1 H, s, NH, ex). 
δC (DMSO-d6): 29.1, 109.4, 116.7, 119.6, 120.1, 130.3, 130.6, 147.6. 
(Z)-11,12-dihydrodibenzo[c,g][1,2]diazocine-3,8-dicarbonitrile 161 
                                                        
To a solution of 5,6,11,12-tetrahydrodibenzo[c,g][1,2]diazocine-3,8-dicarbonitrile 160 (50 mg, 
0.192  mmol) in methanol (3 ml), titanium (III) chloride (25 µl, prepared by diluting 1 ml of ~10 
wt.% solution of TiCl3 in 20-30 wt.% hydrochloric acid with 10 ml of methanol) and 
hydrobromic acid solution (25 µl, prepared by diluting 1 ml of 33% hydrobromic acid in acetic 
acid with 10 ml of methanol) were added using a 50 µl Hamilton syringe at room temperature 
under nitrogen. After a solution of hydrogen peroxide (100 µl, 20% in water, 0.526 mmol) was 
added drop-wise at room temperature, the reaction mixture was stirred at room temperature for 
15 min. The volatiles were removed under reduced pressure and the solid residue was purified by 
column chromatography on silica gel. The appropriate fractions, which were eluted with 
dichloromethane-hexane (30:70 v/v), were combined and concentrated under reduced pressure to 
give the title compound as a light yellow solid (45 mg, 90%). 
Rf (solvent B): 0.65 
HRMS (EI) found 258.09055, C16H10N4 required 258.0905 
δH (CDCl3): 2.85- 3.12 (4 H, m), 7.13- 7.18 (4 H, m), 7.36-7.40 (2 H, dd, J1,2 = 1.5, J1,3 = 7.8). 
δC (CDCl3) 31.5, 111.6, 117.5, 121.0, 122.4, 130.8, 131.1, 132.9. 
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(Z)-11,12-dihydrodibenzo[c,g][1,2]diazocine-3,8-dicarboxylic acid 162 
                                              
Dicarbonitrile 161 (30 mg, 0.115 mmol) was placed in a solution of potassium hydroxide (805 
mg) in ethanol (7 ml) and water (3 ml) and heated under reflux for 4 h. Ethanol was removed 
under reduced pressure and the residue was treated with aqueous hydrochloric acid (6 N) until 
the mixture turned acidic (pH 4). The mixture was extracted with ethyl acetate (2×10 ml). The 
combined organic layers were washed with brine (2×15 ml), dried (MgSO4), and concentrated 
under reduced pressure to give the crude carboxylic acid which was purified by column 
chromatography on silica gel. The appropriate fractions, which were eluted with 
dichloromethane-methanol (94:6 v/v), were combined and concentrated under reduced pressure 
to give the title compound as a light yellow solid ( 25mg, 73%). 
Rf (solvent G): 0.52 
δH(MeOD): 2.93-3.00 (2 H, m), 7.12  (1 H, d, J = 3.9), 7.43 (1 H, s), 7.66 (1 H, d, J = 3.9) 
δC (MeOD): 30.8, 119.3, 127.9, 128.4, 129.5, 131.0, 132.0, 154.9. 
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Synthesis of 4,4'-(ethane-1,2-diyl)dibenzonitrile 158 
                                                              
To a suspension of iron particles (200 mg) in water (5 ml), copper chloride (20 mg, 0.20 mmol) 
was added and stirred at room temperature for 10 min. To the reaction mixture was added 4- 
(bromomethyl) benzonitrile 157 (350 mg, 1.785 mmol). The reaction mixture was stirred at room 
temperature for 12 h. The products were filtered, and the filtrate was extracted with 
dichloromethane (2×10 ml). The organic layers were combined, dried (MgSO4), evaporated to 
dryness under reduced pressure, and purified by column chromatography on silica gel. The 
appropriate fractions, which were eluted with dichloromethane were combined and concentrated 
under reduced pressure to give the title compound as a light yellow solid (150 mg, 72%).  
Rf (solvent B): 0.63 
HRMS (EI): found 232.10005, C12H12N2 required 232.1000 
δH (CDCl3): 3.01 (4 H, s), 7.23 (4 H, d, J = 8.1), 7.58 (4 H, d, J = 8.4) 
δC (CDCl3): 37.2, 110.3, 118.8, 129.1, 129.2, 130.0, 132.3, 146.0 
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Preparation of Iron nanoparticles 
To a solution of ferric chloride (615 mg, 3.78 mmol) in ethanol (15 ml) and water (5 ml) was 
added sodium dodecyl sulfate (200 mg), sodium borohydride (400 mg) in ethanol (10 ml) and 
deionised water (5 ml). The reaction mixture was stirred for 1-2 h after the appearance of black 
precipitate. The products were filtered and the solid was washed with ethanol (20 ml) and 
acetone (20 ml) to obtain the iron nanoparticles.  
Synthesis of cyclic azobenzene incorporated poly(2-hydroxyethyl) 
methacrylate polymer 164 
 Poly (2-hydroxyethyl)methacrylate 163 (26.2 mg, 0.0013 mmol) and cyclic azobenzene 
carboxylic acid 149 (50 mg, 0.2 mmol) were dissolved in dry chloroform (5 ml), followed by 
addition of EDC (42.2 mg, 0.22 mmol) and DMAP (5 mg). The reaction was allowed to proceed 
for 24 h, and the products were extracted with water (10 ml) and chloroform (10 ml). The 
chloroform layer was dried (MgSO4) and concentrated to dryness to obtain pale yellow solid.  
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